Somatoform Disorders
Somatoform disorders are a group of psychiatric conditions characterized by the presence of physical symptoms that cannot be fully explained by a general medical condition, substance use, or another mental disorder, causing significant distress or functional impairment.
1. Definition and Terminology
Somatoform disorders (now reclassified as Somatic Symptom and Related Disorders in DSM-5) represent a group of psychiatric conditions characterised by the presence of physical (somatic) symptoms that cause significant distress and functional impairment, and which are associated with disproportionate and maladaptive thoughts, feelings, and behaviours related to those symptoms [2].
Let's break the name down from its roots:
- "Somato-" (Greek: soma = body) → relating to the body
- "-form" (Latin: forma = shape/appearance) → taking the form of
So "somatoform" literally means "taking the form of a bodily [disease]" — i.e., psychiatric distress manifesting as if it were physical illness.
Understanding the terminology is critical because it has evolved significantly and the naming itself reveals conceptual shifts in how we think about these conditions [2]:
| Term | Definition | Limitations |
|---|---|---|
| Somatization | The expression of emotional distress as bodily symptoms | Assumes symptoms are merely a manifestation of underlying psychopathology — not always true |
| Functional somatic symptoms | Disturbance in bodily function without known structural pathology | Implies a mind-body duality (functional ≠ "not real"); patients may feel dismissed |
| Medically unexplained symptoms (MUS) | Clinical symptoms that cannot be explained by identifiable organic disease | "Unexplainable" is problematic — cause unknown ≠ unexplainable; science may simply not yet understand the mechanism |
Why Did DSM-5 Change the Approach?
The old approach (DSM-IV, ICD-10) required proving that symptoms were "not medically explained" — this forced clinicians into proving a negative. DSM-5 shifted the focus to the positive criterion: the degree of distress, preoccupation, and maladaptive behaviour the patient exhibits in response to their symptoms. Under DSM-5, even patients WITH a known medical condition can receive the diagnosis if their response to symptoms is disproportionate [2].
Medically unexplained symptoms have traditionally been classified from two perspectives:
- Medical approach: Identify patterns of physical symptoms and label them syndromically — e.g., irritable bowel syndrome (IBS), fibromyalgia, chronic fatigue syndrome, non-cardiac chest pain. These are "functional" diagnoses within their respective specialties.
- Psychiatric approach: Identify psychiatric syndromes as the basis of symptoms — e.g., anxiety and depressive disorders, somatoform disorders, factitious disorders.
In reality, these perspectives are complementary, not competing. Many patients sit at the intersection.
2. Epidemiology
- General population: 4–6%
- Primary care patients: ~17% (i.e., roughly 1 in 6 patients presenting to a GP has medically unexplained symptoms — this is remarkably common)
- Illness anxiety disorder specifically: prevalence ~0.75%, though symptoms of health anxiety occur in 5–30% of outpatients [2]
- Sex: Female > Male (approximately 10:1 for somatic symptom disorder in some older studies, though this ratio narrows with DSM-5 criteria)
- Age of onset: Majority begin during adolescence and are established by mid-20s
- Socioeconomic status: More common in those with lower education and lower socio-economic status
- Illness anxiety disorder: M:F ≈ 1:1, more common among unemployed and those with lower education and disability [2]
- Personal history: Childhood chronic illness, sexual abuse, childhood/adult trauma
- Concurrent general medical disorders (especially in older patients — important not to miss organic disease that co-exists)
- Comorbid psychiatric disorders: Both Axis I (depression, dysthymia, anxiety disorders, substance dependence) and Axis II (personality disorders)
- Family history of chronic illnesses
Why Is It More Common in Lower Socioeconomic Groups?
In communities where there is less social acceptance of emotional expression, or where psychological language/literacy is limited, distress is more likely to be channelled through bodily complaints. Additionally, reduced access to mental health services means these patients present to medical services with physical complaints instead [2].
3. Anatomy and Function: The Neurobiology of Somatization
While there is no single "lesion" in somatoform disorders, understanding the relevant neuroanatomy helps explain why emotional distress can produce genuine physical symptoms.
| Brain Region | Role in Somatization |
|---|---|
| Anterior cingulate cortex (ACC) | Integrates emotional and cognitive processing; modulates pain perception. Hyperactivation → amplified awareness of bodily sensations |
| Insular cortex | Primary interoceptive cortex — processes internal body signals (heartbeat, gut sensations, pain). Altered insula function → distorted body signal interpretation |
| Prefrontal cortex (PFC) | Top-down modulation of emotional responses. Reduced PFC regulation → inability to "dampen" alarm signals from the body |
| Amygdala | Threat detection centre. Heightened amygdala reactivity → normal body sensations tagged as "dangerous" |
| Somatosensory cortex | Processes somatic sensations. Increased somatosensory gain → amplification of normal stimuli |
| Hippocampus | Memory consolidation. Links between adverse memories and body schema may perpetuate somatic symptom recall |
The key neurobiological concept is that there are alterations in brain activation related to how adverse events are processed and in the links between emotion, memory, and body schema [2]. In plain terms:
- Normal bodily sensations (e.g., a slight stomach cramp, a muscle twitch) occur in everyone, all the time.
- In patients with somatoform disorders, these sensations are amplified at the cortical level — the brain turns up the volume.
- The amplified signal is then misattributed to a serious medical disease due to dysfunctional health-related assumptions.
- This generates anxiety → further heightens vigilance → selectively confirms fears → a self-perpetuating cycle.
Chronic stress activates the HPA axis, leading to sustained cortisol elevation. This can produce genuine physiological changes:
- Increased muscle tension → pain (headaches, back pain)
- Altered gut motility → nausea, bloating, diarrhoea
- Autonomic dysregulation → palpitations, sweating, dizziness
- Immune dysregulation → fatigue, malaise
This is why somatoform symptoms are real — they are not "made up." The patient genuinely experiences pain, nausea, dizziness. The difference is that the origin is a dysregulated stress-body interface rather than a structural lesion.
4. Aetiology and Pathophysiology
The aetiology is best understood through the biopsychosocial model [2]:
| Factor | Detail |
|---|---|
| Genetics | Heritability 7–21% — modest but real. May be involved in the co-occurrence of anxiety and depression with somatic symptoms [2] |
| Neurobiological | Alterations in brain activation related to processing of adverse events; abnormal links between emotion, memory, and body schema [2]. In illness anxiety disorder: altered plasma neurotrophin-3, platelet 5-HT levels, and pituitary volume [2] |
| Autonomic dysregulation | Chronic sympathetic overdrive produces genuine autonomic symptoms (palpitations, sweating, GI disturbance) |
| Central sensitisation | Repeated activation of pain pathways lowers the threshold for future pain perception — explains why chronic pain syndromes are so common in somatoform disorders |
4.2 Psychological Factors
This is where the major explanatory models live [2]:
- An underlying psychiatric disorder (e.g., depression, anxiety) exists.
- Psychological defences block the expression of this as psychiatric symptoms.
- Instead, the distress is converted into unexplained physical symptoms.
- The patient presents to healthcare with somatic complaints, and the underlying psychiatric disorder remains hidden.
- The patient has an amplifying perceptual style — normal bodily sensations are perceived with greater intensity.
- This leads to the expression of psychological distress as physical symptoms.
- An underlying psychiatric disorder may or may not be present.
- The patient holds over-inclusive/unrealistic concepts of good health (e.g., "I should never feel any discomfort").
- Dysfunctional assumptions about the prevalence and communicability of severe illnesses (e.g., "headache usually means a brain tumour").
- This leads to increased attention to bodily sensations → maladaptive interpretation → anxiety → more attention → cycle.
- Alexithymia (Greek: a- = without, lexis = words, thymos = emotions): literally "without words for emotions."
- Difficulty identifying, describing, and expressing emotions.
- Psychological distress that cannot be verbalised is instead expressed through the body.
- Psychological distress acts as a catalyst to seek medical care for common, innocuous physical symptoms that would otherwise be ignored.
- The healthcare system may inadvertently reinforce this (investigations, specialist referrals, follow-ups).
| Factor | Detail |
|---|---|
| Developmental factors | Poor emotional awareness during childhood; higher levels of negative emotions in childhood [2] |
| Childhood adverse experiences | Inadequate food, clothing, attention; insecure attachment [2] |
| Abuse | Sexual abuse, childhood physical abuse — strong risk factors [2] |
| Personality factors | Often already very health-conscious in adolescence [2] |
| Socioeconomic | Lower socio-economic status, lower education [2] |
| Cultural factors | In cultures where social acceptance of emotional expression is low, distress tends to be expressed as MUS [2]. This is particularly relevant in Hong Kong and broader East Asian cultures, where stigma around mental illness remains significant and somatic complaints are a culturally sanctioned form of expressing distress |
Hong Kong Context
In Hong Kong, the concept of neurasthenia (神經衰弱, shenjing shuairuo) — characterised by fatigue, headaches, dizziness, poor concentration, and sleep disturbance — remains a culturally important idiom of distress. ICD-10 retains neurasthenia as a diagnosis (F48.0), though DSM-5 does not. Many patients who would be classified as having somatic symptom disorder in DSM-5 present with neurasthenia-like complaints in Hong Kong primary care. Understanding this cultural context is essential for effective communication and management.
5. Classification
The classification has undergone major changes across ICD-10, DSM-IV, and DSM-5 [2]:
| ICD-10 | DSM-IV | DSM-5 |
|---|---|---|
| Somatization disorder | Somatization disorder | Somatic symptom and related disorders |
| Undifferentiated somatoform disorder | Undifferentiated somatoform disorder | Somatic symptom and related disorders |
| Hypochondriacal disorder | Hypochondriasis | Illness anxiety disorder |
| Somatoform autonomic dysfunction | No category | No category |
| Persistent pain disorder | Pain disorder associated with psychological factors (and a general medical condition) | Somatic symptom disorder with predominant pain, or psychological factors affecting other medical conditions |
| Other somatoform disorders | Somatoform disorders NOS | Unspecified somatic symptom disorder |
| No category | Body dysmorphic disorder | Moved to Obsessive-Compulsive and Related Disorders |
| No category | Conversion disorder | Functional neurological symptom disorder |
| Neurasthenia | No category | No category |
The key DSM-5 conditions under this umbrella [2]:
-
Somatic Symptom Disorder (SSD) — the "core" disorder
- Previously: somatoform disorder / Briquet syndrome
- Emphasises disproportionate distress/behaviour in response to somatic symptoms
- Does NOT require symptoms to be medically unexplained
-
Illness Anxiety Disorder (IAD)
- Previously: hypochondriasis
- Preoccupation with having a serious illness
- Minimal or no somatic symptoms (if significant somatic symptoms present → classify as SSD instead)
-
Functional Neurological Symptom Disorder (FND)
- Previously: conversion disorder / hysteria
- Neurological symptoms (weakness, paralysis, seizures, sensory loss) incompatible with recognised neurological disease
- The "conversion" refers to the psychodynamic concept of converting psychological conflict into neurological symptoms
-
Psychological Factors Affecting Other Medical Conditions
- A known medical condition exists, but psychological factors adversely affect its course
-
Factitious Disorder
- Now classified under this umbrella in DSM-5
- Conscious fabrication of symptoms, but unconscious motivation (to assume the sick role)
Critical Distinction Table
| Insight into psychological basis | Illness behaviour | Motivation | |
|---|---|---|---|
| Somatoform disorders | None (unconscious process) | Feels genuinely ill (unconscious process) | ?Due to underlying psychological distress |
| Factitious disorders | None (unconscious process) | Feels ill (conscious process — deliberately fabricates symptoms) | To assume the sick role |
| Malingering | Conscious process | Does NOT feel ill; aims to look ill | External gain (money, avoiding work/prison, drugs) |
This distinction is extremely high-yield for exams. The key differentiator is the level of consciousness at each step [2].
6. Clinical Features
6.1 Somatic Symptom Disorder — Symptoms and Signs
The clinical presentation of somatic symptom disorder involves two domains: the somatic symptoms themselves and the maladaptive psychological/behavioural response [2].
One or more somatic symptoms that are distressing and/or result in significant disruption of daily life [2]. The symptom may be long-standing, and while a single distressing somatic symptom is sufficient for diagnosis, a high number of somatic complaints is associated with poorer outcome [2].
| System | Common Symptoms | Pathophysiological Basis |
|---|---|---|
| Non-specific | Fatigue, syncope, dizziness | HPA axis activation → cortisol excess → fatigue. Autonomic dysregulation → vasovagal tendency → syncope/presyncope. Hyperventilation from anxiety → respiratory alkalosis → dizziness |
| Pain | Joint pain, limb pain, back pain, headache, chest pain, abdominal pain, dysuria, diffuse pain | Central sensitisation: repeated activation of nociceptive pathways lowers pain thresholds. Chronic muscle tension from sympathetic overdrive → myofascial pain. Visceral hypersensitivity (especially GI pain) |
| Gastrointestinal | Nausea, vomiting, abdominal pain, bloating, gas, diarrhoea | Gut-brain axis dysregulation: stress → vagal and enteric nervous system activation → altered motility, visceral hypersensitivity. Excess cortisol → increased gastric acid, altered mucosal blood flow |
| Cardiovascular/Respiratory | Chest pain, shortness of breath, palpitations | Sympathetic overdrive → tachycardia, awareness of heartbeat (palpitations). Hyperventilation → chest wall tightness, air hunger. Non-cardiac chest pain from musculoskeletal tension or oesophageal dysmotility |
| Neurological | Movement disorders, sensory loss, weakness, paralysis | In conversion (FND): functional disconnection between motor planning areas (supplementary motor area) and primary motor cortex — the "intention to move" fails to reach execution, despite intact structural pathways |
| Urogenital | Dyspareunia, dysmenorrhoea, erectile dysfunction | Pelvic floor hypertonicity from chronic stress → dyspareunia. Autonomic imbalance → erectile dysfunction. Altered prostaglandin sensitivity → dysmenorrhoea |
This is the defining feature that distinguishes SSD from simply having physical symptoms:
| Feature | Explanation |
|---|---|
| Disproportionate cognitive/emotional/behavioural responses | The level of worry, distress, and time devoted to health concerns is far out of proportion to the actual severity of the symptom. A mild headache might trigger days of anguish and multiple emergency visits. |
| Variable insight | Some patients recognise their worry is irrational; others are convinced they have a serious disease. This ranges from good insight → poor insight → delusional conviction. |
| Excessive checking behaviours | e.g., excessive BP checking, excessive breast self-examination, compulsive Googling of symptoms, repeated self-palpation of lymph nodes |
| High healthcare utilisation | Doctor-shopping, multiple examinations/investigations, pressing doctors to order more invasive diagnostic tests. Repeated negative workups do NOT alleviate their fears [2] — this is a cardinal feature. |
| Comorbid anxiety/depression (30–60%) | Some somatic symptoms may actually arise from these comorbid disorders (e.g., fatigue and poor concentration from depression, palpitations and chest tightness from panic disorder) [2] |
Exam Tip
When you see a patient who has had multiple negative investigations across multiple specialties and continues to seek further tests despite reassurance — think somatic symptom disorder. The key is not the absence of organic disease, but the disproportionate and maladaptive response to symptoms.
- Chronic, fluctuating course: 50–75% may eventually improve, but rarely completely resolve and may relapse subsequently
- Negative prognostic factors:
- Older age
- Greater severity and number of complaints
- Comorbid depression/anxiety
- Maladaptive personality traits (e.g., harm avoidance, low cooperativeness)
- Potential complications:
- Unnecessary invasive procedures with iatrogenic complications (e.g., exploratory laparotomy, repeated endoscopy, unnecessary biopsies)
- Substance use disorders in attempt to manage distress — e.g., narcotic analgesics, benzodiazepines [2]
6.3 Conversion (Functional Neurological Symptom) Disorder [2]
- Unclear, but involves biological, psychological, and social factors [2]:
- Cognitive: Maladaptive exaggeration of minor symptoms due to assumption of severe underlying disease
- Neurobiological: Altered brain structure and function on imaging studies — particularly abnormal connectivity between limbic regions and motor/sensory cortex
- Psychodynamic: Classical description of a conversion of subconscious psychological conflict into somatic signs and symptoms
| Feature | Examples | Pathophysiological Basis |
|---|---|---|
| Non-epileptic seizures | "Pseudoseizures" — but this term is increasingly avoided as pejorative | Dissociative mechanism: limbic system "overrides" cortical control. Unlike true epileptic seizures, EEG is normal during the event. Eyes typically closed (eyes open in true seizures). |
| Weakness/paralysis | Hemiparesis, paraparesis, monoparesis | Functional disconnection between volitional motor planning areas and primary motor cortex. Hoover's sign positive: involuntary hip extension when flexing contralateral hip, but weakness of voluntary hip extension on the same side. |
| Movement disorders | Tremor, dystonia, myoclonus, gait disorder | Functional tremor: variable frequency, distractible (changes/stops when attention diverted to another task). Entrainment sign positive. |
| Speech disturbances | Dysphonia, mutism, stuttering | Functional disconnection in speech motor areas |
| Globus sensation | Sensation of a lump in the throat | Cricopharyngeal muscle tension from autonomic arousal |
| Sensory symptoms | Numbness, paraesthesia | Does not follow dermatomal or peripheral nerve distribution — often "non-anatomical" patterns (e.g., exact midline split in sensation) |
| Visual symptoms | Tunnel vision, blindness | Functional visual loss: optokinetic nystagmus preserved (impossible if truly blind). Intact pupillary reflexes. |
| Cognitive symptoms | Pseudodementia-like presentation | Functional cognitive disorder |
- Symptoms are highly suggestible: vary considerably in response to comments of other people, especially doctors
- Can be reinforced by treatment measures — e.g., providing a wheelchair for a patient who has difficulty walking may perpetuate the symptom
- ± La belle indifférence: Some patients are surprisingly unconcerned about their symptoms — though this is not pathognomonic and can occur in organic disease too
- Psychiatric comorbidities (up to 90%): depression (32%), GAD (21%), panic disorder (36%), dissociation (47%), personality disorders (e.g., borderline, histrionic, narcissistic) [2]
6.4 Illness Anxiety Disorder (Previously Hypochondriasis) [2]
- Prevalence: 0.75% (but health anxiety symptoms occur in 5–30% of outpatients)
- Demographics: M:F ≈ 1:1, more common among unemployed, lower education, disability
The core feature is preoccupation with having or acquiring a serious illness despite minimal or no somatic symptoms:
| Feature | Pathophysiological Basis |
|---|---|
| Preoccupation with having a serious illness | Normal body sensations are perceived abnormally intensely → misattributed to serious medical disease due to dysfunctional health-related assumptions [2] |
| Excessive health-related anxiety | The misattribution generates excessive health-related anxiety → drives maladaptive reassurance-seeking behaviour [2] |
| Maladaptive behaviour | Excessive body checking, repeated medical consultations, internet searching ("cyberchondria"), or alternatively phobic avoidance of medical settings |
| Increased vigilance | Heightened monitoring of bodily sensations → selectively confirms fears and negates the effect of reassurance [2] |
| Reinforcement cycle | Reassurance provides brief relief → anxiety returns → seeks more reassurance → cycle perpetuates [2] |
- Neurobiology: Altered plasma neurotrophin-3, platelet 5-HT, pituitary volume [2]
- Cognitive basis: Normal body sensation perceived abnormally intensely → misattributed to serious disease → excessive health anxiety → maladaptive behaviour → increased vigilance → selectively confirms fears → reinforces persistent preoccupation [2]
6.5 Body Dysmorphic Disorder (BDD) [2]
Note: In DSM-5, BDD has been moved to Obsessive-Compulsive and Related Disorders, but it is discussed here due to historical links to somatoform disorders.
- Prevalence: 2–4%, commonly underdiagnosed
- Genetics: Heritability 43%, associated with GABA-A γ2 receptor gene
- Neurobiology: Abnormal visual processing on fMRI, impaired executive function
- Psychosocial: Childhood neglect and abuse
| Feature | Details |
|---|---|
| Preoccupation with perceived defect | Non-existent or slight defects in physical appearance of ≥1 body parts. Usually perceived as unattractive, abnormal, or deformed → very distressing. Common areas: skin, hair, nose, stomach, breast/chest, eyes, symmetry |
| Compulsions (rituals) | Repetitive behaviours driven by appearance preoccupations: camouflaging (~90%), comparing (90%), mirror checking (90%), excessive grooming (> 50%), seeking reassurance (50%), clothes changing, skin picking, excessive exercising, compulsive shopping |
| Poor insight | Often associated with overvalued ideas or even delusions |
| Ideas/delusions of reference (~60%) | Belief that others take special notice of their perceived defect, talk about or make fun of their appearance → social avoidance |
| Social anxiety and avoidance | Can mimic social anxiety disorder |
| Emotional distress | Decreased self-esteem, depressed mood, guilt, shame, perfectionism, neuroticism |
| Suicide risk | ~80% lifetime risk of suicidal ideation, ~25% attempt [2] — this is very high and must not be overlooked |
Depression (75%), social anxiety (40%), personality disorder (40–100%), substance use disorders (30–50%), OCD (33%), eating disorder (33%), panic disorder (13–20%)
Typically chronic; recovery in only ~20%
6.6 Suggestive Features from History and Examination [2]
- Vague, inconsistent HPI mixed with normal physical sensations and abnormal checking behaviour
- Symptoms do not fit into known disease patterns or anatomical confines
- Persistent anxiety and concern despite repeated help-seeking, reassurance, negative investigations, and treatment [2]
- Must be thorough — to exclude any insidious underlying organic condition
- Remember: the purpose of examination is dual — to rule out organic disease AND to demonstrate to the patient that you are taking their symptoms seriously
- Must be judicious — false-positive results may lead to unnecessary invasive investigations and risks
- The challenge: too few investigations risks missing organic disease; too many investigations reinforces the illness behaviour cycle and exposes patients to iatrogenic harm
The Investigation Trap
A common mistake is to keep ordering investigations to "reassure" the patient. In somatoform disorders, negative results do NOT provide lasting reassurance. Each new investigation can paradoxically reinforce the patient's belief that something serious is being looked for, and any incidental/false-positive finding can trigger further anxiety and invasive workup. Be targeted, not exhaustive.
7. Approach to Medically Unexplained Symptoms [2]
The approach requires systematic exclusion of organic causes FIRST:
These principles form the foundation of the initial clinical approach:
- Emphasise that the symptoms are real and familiar to the clinician
- Explain the role of psychosocial factors in ALL medical conditions (not just "psychiatric" ones)
- Offer and discuss a psychosocial explanation of the symptoms
- Allow adequate time for the patient and partner/family to ask questions
- Agree a treatment plan to include:
- Treatment of any minor medical problem contributing to the symptoms
- Treatment of any associated psychiatric disorder (commonly anxiety or depression)
- If appropriate: improve fitness by graded activity
- If appropriate: diary keeping to explore the relationship between symptoms and possible psychosocial causes
High Yield Summary
Definition: Somatoform disorders = psychiatric conditions where physical symptoms cause significant distress with disproportionate maladaptive thoughts, feelings, and behaviours. DSM-5 renamed these "Somatic Symptom and Related Disorders."
Key Conceptual Shift (DSM-5): No longer requires symptoms to be "medically unexplained" — focuses on the disproportionate response to symptoms.
Epidemiology: 4–6% general population, 17% primary care. F > M. Onset in adolescence/early adulthood. Lower SES and education.
Aetiology — Biopsychosocial:
- Biological: Genetics (7–21% heritability), neurobiological alterations in emotion-body schema processing
- Psychological: Amplifying perceptual style, illness-related beliefs, alexithymia, psychodynamic conversion
- Social: Childhood adversity/abuse, low SES, cultural suppression of emotional expression (highly relevant in Hong Kong)
Classification (DSM-5):
- Somatic Symptom Disorder (SSD): ≥1 distressing somatic symptom + disproportionate response (≥6 months)
- Illness Anxiety Disorder (IAD): Preoccupation with serious illness, minimal/no somatic symptoms
- Functional Neurological Symptom Disorder (FND): Neurological symptoms incompatible with recognised disease
- Body Dysmorphic Disorder: Now under OCD-related disorders
Key Clinical Features:
- Multiple somatic symptoms across systems (pain, GI, CVS, neuro, urogenital)
- Disproportionate worry, checking behaviours, doctor-shopping
- Negative workups do NOT reassure
- Comorbid anxiety/depression in 30–60%
Critical Distinctions:
- Somatoform = unconscious/unconscious/psychological distress
- Factitious = unconscious/conscious/sick role
- Malingering = conscious/deliberate/external gain
Course: Chronic, fluctuating. 50–75% improve, rarely fully resolve. Complications: iatrogenic harm from unnecessary procedures, substance use disorders.
Investigation Principle: Be judicious — too many investigations reinforce illness behaviour and risk iatrogenic harm.
Active Recall - Somatoform Disorders
Differential Diagnosis of Somatoform Disorders
The differential diagnosis of somatoform (somatic symptom and related) disorders is one of the most nuanced exercises in psychiatry. The reason is simple: these disorders sit at the crossroads of medicine and psychiatry, and the symptom overlap with both organic disease and other psychiatric conditions is enormous. Approaching this systematically is therefore essential.
The cardinal rule before considering any psychiatric differential: you must diligently rule out organic causes before considering a psychiatric diagnosis [2]. Somatoform disorders are never a diagnosis of exclusion by convenience — they are a positive diagnosis made on the basis of specific features (disproportionate distress and maladaptive behaviour), but only after adequate medical evaluation.
The differential can be organised into three tiers:
- Organic (medical) disorders — must always be excluded first
- Other psychiatric disorders that produce somatic symptoms — the most common source of diagnostic confusion
- Other somatoform-spectrum conditions — differentiating between subtypes within the somatoform umbrella
- Intentional symptom production — factitious disorder and malingering
This is the most critical step. Insidious, multisystem diseases can mimic somatoform disorders for months or years before declaring themselves [2].
| Organic Condition | Why It Mimics Somatoform Disorders | Key Differentiating Features |
|---|---|---|
| Systemic lupus erythematosus (SLE) | Fatigue, joint pain, diffuse pain, neuropsychiatric symptoms — all vague and fluctuating early on | Look for malar rash, photosensitivity, oral ulcers, serositis. Check ANA, anti-dsDNA, complement levels. |
| Multiple sclerosis (MS) | Sensory symptoms, weakness, fatigue, visual disturbance — can present with "non-anatomical" patterns initially | MRI brain/spine with demyelinating lesions, oligoclonal bands in CSF. Symptoms should follow white matter tract anatomy on detailed examination. |
| Hyperparathyroidism | "Bones, stones, abdominal moans, psychic groans" — fatigue, diffuse pain, GI disturbance, cognitive complaints | Check serum calcium, PTH. Hypercalcaemia is the giveaway. |
| Hyperthyroidism / Hypothyroidism | Palpitations, anxiety, tremor, fatigue, weight changes, GI disturbance | TFTs (TSH, free T4). Thyroid disorders are extremely common and must always be screened. |
| Occult malignancy | Fatigue, weight loss, diffuse pain, paraneoplastic neurological syndromes | Age-appropriate cancer screening. Unexplained weight loss, night sweats, lymphadenopathy should raise alarm. |
| HIV/AIDS | Fatigue, weight loss, neuropsychiatric symptoms, diffuse lymphadenopathy | Risk factor assessment, HIV serology. Particularly relevant in Hong Kong with rising HIV incidence among men who have sex with men. |
| Chronic infections (e.g., TB, endocarditis, hepatitis) | Fatigue, weight loss, vague systemic complaints | Infection markers (CRP, ESR, blood cultures), targeted serology. TB remains relevant in Hong Kong. |
| Phaeochromocytoma | Episodic palpitations, sweating, headache, anxiety — classic mimic of panic/somatoform disorder | 24-hour urine catecholamines/metanephrines, plasma metanephrines. Paroxysmal hypertension. |
| Coeliac disease / malabsorption | GI symptoms (bloating, diarrhoea, abdominal pain), fatigue, iron deficiency | Anti-tTG antibodies, duodenal biopsy. |
| Pituitary failure | Fatigue, weakness, weight changes, amenorrhoea, reduced libido | Pituitary hormone panel (cortisol, TSH, LH/FSH, prolactin, GH). |
The DSM-5 Nuance on Organic Disease
Under DSM-5 criteria, the presence of a known organic disease does NOT exclude a diagnosis of somatic symptom disorder [2]. Conversely, medically unexplained symptoms alone do NOT qualify for the diagnosis. The diagnosis centres on whether the patient's cognitive, emotional, and behavioural responses are disproportionate to the symptom's expected severity. So a patient with well-controlled type 2 diabetes who spends 6 hours daily researching diabetic complications, checks their blood sugar 20 times a day, and visits the emergency department weekly despite stable HbA1c — that patient meets criteria for SSD even though their underlying condition is entirely organic.
This is where the exam questions live. Each of these conditions can produce prominent somatic symptoms, and the key is knowing the specific differentiating features [2].
| Differential Diagnosis | Shared Features with Somatoform Disorders | Key Differentiating Features | Why This Distinction Matters |
|---|---|---|---|
| Major Depressive Disorder | Somatization is very common in depression — fatigue, pain, sleep disturbance, appetite change, psychomotor retardation are all "somatic" | If somatic symptoms and related concerns do not occur outside of depressive episodes, then SSD is not diagnosed [2]. Look for core depressive features: persistent low mood, anhedonia, guilt, worthlessness, suicidal ideation, diurnal mood variation, early morning wakening. Somatic symptoms remit when depression remits [2]. | Depression is treatable with antidepressants — if you misdiagnose as SSD and don't treat the depression, the patient won't improve |
| Generalised Anxiety Disorder (GAD) | Both marked by high levels of anxiety and somatic symptoms (palpitations, GI disturbance, muscle tension, fatigue) [2] | In GAD, anxiety is pervasive over multiple aspects of life (finances, work, family, health, future) — not limited to bodily symptoms [2]. In SSD, the preoccupation is focused specifically on somatic symptoms and their implications. GAD patients worry about everything; SSD patients worry about their bodies. | Treatment strategies differ — GAD responds well to SSRI + CBT targeting generalised worry patterns, whereas SSD requires CBT targeting illness beliefs specifically |
| Panic Disorder | Panic attacks produce dramatic somatic symptoms (chest pain, palpitations, dyspnoea, dizziness, paraesthesiae, nausea) — patients genuinely fear they are dying | Panic attacks are episodic and typically last 10–30 minutes. There is anticipatory anxiety about the next attack and catastrophic thoughts about acute life-threatening illness ("I'm having a heart attack") [2]. SSD tends to be more enduring and chronic with persistent preoccupation rather than episodic peaks [2]. Panic disorder features unexpected (uncued) attacks. | Panic disorder has very specific treatment (CBT for panic, SSRI, respiratory retraining) |
| Obsessive-Compulsive Disorder (OCD) | May have health/hygiene-related obsessions and compulsive checking (e.g., contamination fears → excessive handwashing, health checking) | In OCD, the thoughts are experienced as intrusive, ego-dystonic, and unwanted [2]. The compulsive behaviour specifically aims to reduce anxiety arising from the intrusive thought (not to investigate a symptom). OCD compulsions are typically ritualistic/rule-driven and may be clearly excessive or unrelated to the feared outcome [2]. In SSD, checking behaviour is directly related to health concerns and not ritualistic. | OCD has specific pharmacotherapy (high-dose SSRI) and psychotherapy (ERP — exposure and response prevention) |
| Illness Anxiety Disorder (IAD) | Both involve maladaptive responses to somatic concerns [2] | In IAD, somatic symptoms are minimal or absent [2]. The patient's primary concern is having an undiagnosed serious disease and they seek diagnosis (investigations) rather than relief of symptoms (treatment) [2]. In SSD, the patient has prominent somatic symptoms and seeks relief from the distress those symptoms cause. IAD patients may also fear treatment side effects and be reluctant to take medication, whereas SSD patients may push for medications including narcotics [2]. | If significant somatic symptoms are present → diagnose SSD, not IAD |
| Functional Neurological Symptom Disorder (FND / Conversion Disorder) | Both are under the somatoform spectrum | FND presents specifically with neurological symptoms (weakness, paralysis, seizures, sensory loss, movement disorders) that are incompatible with recognised neurological disease [2]. SSD presents with distress caused by symptoms across any body system. The maladaptive cognitive/emotional/behavioural features may not be present in FND patients [2] — i.e., a patient with functional weakness may not show the excessive health preoccupation seen in SSD. | FND management emphasises physiotherapy for motor symptoms and specific neurological rehabilitation, rather than the CBT-for-illness-beliefs approach used in SSD |
| Delusional Disorder (somatic subtype) | Belief that something is wrong with one's body [2] | The belief reaches delusional intensity — it is fixed, unshakeable, not amenable to reason, and often bizarre (e.g., "insects are crawling under my skin," "my organs are rotting") [2]. In somatoform disorders, illness-related beliefs are usually overvalued ideas — strongly held but the patient can entertain doubt when challenged (at least partially). | Delusional disorder requires antipsychotic treatment; somatoform disorders do not |
| Body Dysmorphic Disorder (BDD) | Excessive preoccupation with a body-related concern [2] | In BDD, the concern is about a perceived defect in physical appearance — the patient thinks they look abnormal/ugly [2]. In SSD, the concern reflects fear of underlying illness and the distress brought on by the symptom itself, not a defect in appearance [2]. | BDD is classified under OCD-related disorders in DSM-5 and treated with high-dose SSRI + CBT |
| Social Anxiety Disorder | Somatic symptoms in social situations (blushing, tremor, sweating, palpitations, nausea) | Symptoms are situation-specific — triggered by social/performance situations where the patient fears evaluation by others [2]. Outside social situations, the patient is well. In SSD, preoccupation is with the symptoms themselves, not the social context. | Different CBT focus (social skills training, cognitive restructuring of social fears) |
| Adjustment Disorder | Anxiety and somatic symptoms following a stressor | Must develop within 3 months of an identifiable stressor. Symptoms are expected to resolve within 6 months after the stressor ceases [2]. Does not meet criteria for a specific mood or anxiety disorder. In SSD, the course is chronic (≥6 months) and the focus is specifically on somatic symptoms. | Adjustment disorder is generally self-limiting |
| PTSD | Somatic symptoms (hyperarousal, pain, fatigue) are common | Requires exposure to a traumatic event. Core features are re-experiencing (flashbacks, nightmares), avoidance of trauma reminders, negative cognitions/mood, and hyperarousal [2]. Somatic symptoms are secondary to the trauma response, not the primary focus of preoccupation. | Trauma-focused CBT and EMDR are first-line; very different from SSD management |
This tier is conceptually distinct because it involves some degree of conscious intent — in contrast to somatoform disorders where the process is entirely unconscious [2].
| Condition | Insight into Psychological Basis | Illness Behaviour | Motivation | Key Differentiating Features |
|---|---|---|---|---|
| Somatoform Disorders | None (unconscious) | Feels genuinely ill (unconscious) | ?Underlying psychological distress [2] | Patient genuinely suffers; believes symptoms are real; seeks help |
| Factitious Disorder | None (unconscious motivation) | Feels ill — but consciously fabricates/induces symptoms [2] | To assume the sick role (primary gain) [2] | May present to multiple hospitals under different names. May have extensive medical knowledge. Munchausen syndrome = chronic, severe form. Munchausen syndrome by proxy = caretaker inducing illness in child (a form of child abuse) [2]. |
| Malingering | Conscious process [2] | Does NOT feel ill — deliberately aims to look ill [2] | Secondary (external) gain — insurance money, avoiding work/prison/military service, obtaining drugs [2] | Medicolegal context raises suspicion [2]. Marked discrepancy between claimed disability and objective findings [2]. Vague reports loaded with overgeneralisations that may seem rehearsed [2]. Once objective is achieved, symptoms lose significance [2]. Rejects all treatment that does not include psychoactive medications [2]. Exhibits lack of cooperation with diagnostic/treatment interventions [2]. Possible underlying antisocial personality disorder [2]. |
Ganser's Syndrome
Ganser's syndrome was first described in prisoners [2]. Its characteristic features include: (1) giving approximate answers to questions designed to test intellectual function (e.g., answering "5" to 2+2 — close but wrong, suggesting they actually know the answer), (2) psychogenic physical symptoms, (3) hallucinations, and (4) apparent clouding of consciousness [2]. It is considered by some to be a form of malingering, but the behaviour may be so consistent that it reflects genuine underlying distress — a way of communicating distress among individuals with limited psychological vocabulary [2]. Must rule out organic brain disease and schizophrenia, especially if associated with psychotic features, visual hallucinations, or muddled thinking [2].
This is a critical skill for the exam — knowing which somatoform subtype to assign [2]:
| Feature | Somatic Symptom Disorder | Illness Anxiety Disorder | Functional Neurological Symptom Disorder | Body Dysmorphic Disorder |
|---|---|---|---|---|
| Somatic symptoms | ≥1, prominent and distressing | Minimal or none | Neurological symptoms specifically | Perceived physical appearance defect |
| Core concern | Distress from symptoms | Having an undiagnosed serious illness | Neurological deficit | Appearance |
| What patient seeks | Relief of symptoms (treatment) | Diagnosis (investigation) | Explanation for neurological problem | Reassurance about appearance, or cosmetic surgery |
| Maladaptive behaviour | Prominent — excessive checking, doctor-shopping | Prominent — excessive scanning for illness signs | May or may not be present | Compulsions (mirror checking, camouflaging, comparing) |
| Duration criterion | ≥6 months (DSM-5) | ≥6 months | No minimum specified | No minimum specified |
| Insight | Variable | Variable | Often with la belle indifférence (but non-specific) | Often poor — overvalued ideas to delusional |
| DSM-5 classification | Somatic symptom and related disorders | Somatic symptom and related disorders | Somatic symptom and related disorders | OCD and related disorders |
| Differentiating Question | If YES → Think... | If NO → Think... |
|---|---|---|
| Are symptoms consciously produced? | Factitious disorder or malingering | Somatoform spectrum or other psychiatric disorder |
| Is there external gain? | Malingering | Factitious disorder (sick role is the gain) |
| Are symptoms exclusively neurological? | FND (conversion disorder) | SSD or IAD |
| Is the concern primarily about having an undiagnosed disease with minimal symptoms? | Illness Anxiety Disorder | SSD (if symptoms are prominent) |
| Is the concern about physical appearance? | BDD | SSD |
| Does belief reach delusional intensity? | Delusional disorder, somatic subtype | Somatoform disorders (overvalued ideas) |
| Are thoughts ego-dystonic, intrusive, and ritualistic? | OCD | SSD |
| Do somatic symptoms only occur during mood episodes? | Depression with somatic features | SSD (independent of mood episodes) |
| Is anxiety about health AND multiple other life domains? | GAD | SSD (if focused on health) |
High Yield Summary — Differential Diagnosis
Step 1: Always exclude organic disease first — SLE, MS, hyperparathyroidism, thyroid disorders, occult malignancy, HIV, chronic infections, phaeochromocytoma.
Step 2: Distinguish unconscious vs conscious symptom production — somatoform (unconscious/unconscious) vs factitious (unconscious motivation/conscious fabrication) vs malingering (conscious/conscious, external gain).
Step 3: Within the somatoform spectrum — differentiate by (a) whether symptoms are neurological (FND), (b) whether symptoms are minimal with preoccupation about having disease (IAD), (c) whether concern is about appearance (BDD), or (d) whether there is disproportionate response to prominent somatic symptoms (SSD).
Step 4: Distinguish from other psychiatric disorders — Depression (symptoms remit outside episodes), GAD (anxiety pervasive beyond health), Panic disorder (episodic, anticipatory anxiety about attacks), OCD (intrusive, ego-dystonic thoughts with ritualistic compulsions), Delusional disorder (fixed, unshakeable beliefs at delusional intensity), PTSD (trauma exposure required), Adjustment disorder (identifiable stressor, self-limiting).
Key DSM-5 principle: The presence of organic disease does NOT exclude SSD. The absence of organic disease does NOT alone qualify for SSD. The diagnosis is about the disproportionate response.
Active Recall - Differential Diagnosis of Somatoform Disorders
References
[2] Senior notes: ryanho-psych.md (Sections 8.4.1, 8.4.2.1, 8.4.2.2, 8.4.2.3 — Approach to MUS, Somatic Symptom Disorder, Illness Anxiety Disorder, Other Related Disorders including factitious disorder and malingering)
Diagnostic Criteria
Diagnosis of somatoform disorders is fundamentally a clinical diagnosis — there is no blood test, imaging study, or biomarker that confirms it. The diagnosis rests on recognising a specific pattern of symptoms AND maladaptive responses, after appropriate exclusion of organic disease. Understanding the diagnostic criteria in both ICD-10 and DSM-5 is essential because they differ significantly in philosophy [2].
Before diving into specifics, recall that psychiatric diagnostic criteria typically consist of:
- Core (discriminating) symptoms — present in the defined disorder but seldom in others
- Associated (characteristic) symptoms — frequent but also seen in other disorders
- Minimal duration of symptoms
- Distress or impairment in functioning
- Exclusion criteria — ruling out other explanations
A. Somatic Symptom Disorder
This is the "core" diagnosis in the somatoform spectrum. The ICD-10 and DSM-5 criteria differ substantially, and understanding why they differ is just as important as memorising them [2].
| Criterion | Requirement | Explanation |
|---|---|---|
| A | ≥1 somatic symptoms that are distressing or result in significant disruption of daily life [2] | Note: only ONE symptom is needed. The symptom does NOT need to be medically unexplained — this is the key DSM-5 shift. A patient with known coronary artery disease whose chest pain causes disproportionate distress qualifies. |
| B | Excessive thoughts, feelings, or behaviours related to the somatic symptoms or associated health concerns, as manifested by at least one of: (1) Disproportionate and persistent thoughts about the seriousness of one's symptoms; (2) Persistently high level of anxiety about health or symptoms; (3) Excessive time and energy devoted to these symptoms or health concerns [2] | This is the positive diagnostic criterion that makes DSM-5 fundamentally different from ICD-10. The diagnosis is about the response to symptoms, not the absence of organic explanation. Only ONE of the three manifestations is required. |
| C | Although any one somatic symptom may not be continuously present, the state of being symptomatic is persistent (typically > 6 months) [2] | Individual symptoms may come and go, but the patient remains chronically symptomatic. The 6-month threshold reflects the chronic nature of the disorder and prevents over-diagnosis of transient illness behaviour. |
DSM-5 Specifiers:
- With predominant pain — for patients where pain is the dominant symptom (replaces the old DSM-IV "pain disorder")
- Persistent — severe symptoms, marked impairment, long duration (> 6 months)
- Severity: Mild (only 1 of criterion B symptoms), Moderate (≥2 of criterion B), Severe (≥2 of criterion B + multiple somatic complaints or one very severe somatic complaint)
| Criterion | Requirement | Explanation |
|---|---|---|
| (a) | ≥2 years of multiple and variable physical symptoms for which no adequate physical explanation has been found [2] | Much stricter than DSM-5: requires 2 years (vs 6 months), requires MULTIPLE symptoms (vs ≥1), and critically requires that symptoms be medically unexplained |
| (b) | Persistent refusal to accept the advice or reassurance of several doctors that there is no physical explanation for the symptoms [2] | This criterion captures the maladaptive health behaviour — the doctor-shopping and resistance to reassurance |
| (c) | Some degree of impairment of social and family functioning attributable to the nature of the symptoms and resulting behaviour [2] | Functional impairment criterion |
ICD-10 vs DSM-5: Why Does It Matter?
The ICD-10 approach is more restrictive: it requires medically unexplained symptoms, multiple symptoms, 2-year duration, and refusal of reassurance. The DSM-5 approach is broader and more clinically practical: it does not require symptoms to be unexplained, needs only 1 symptom, requires only 6 months, and focuses on the disproportionate psychological/behavioural response. In practice, many patients who would not meet ICD-10 criteria for somatization disorder DO meet DSM-5 criteria for somatic symptom disorder. Hong Kong uses ICD coding for administrative purposes but clinical teaching increasingly follows DSM-5 conceptualisation [2].
Key Exam Point
One single distressing somatic symptom is sufficient for DSM-5 diagnosis, but a high number of somatic complaints is associated with poorer outcome [2]. Do not confuse "sufficient for diagnosis" with "typical presentation."
B. Illness Anxiety Disorder
| Criterion | Requirement | Explanation |
|---|---|---|
| A | Preoccupation with having or acquiring a serious illness [2] | The core feature. The patient is consumed by the idea that they have (or will develop) a serious disease. |
| B | Somatic symptoms are not present or, if present, are only mild in intensity. If another medical condition is present or there is high risk for developing one, the preoccupation is clearly excessive or disproportionate [2]. | This is the critical separator from SSD: if prominent somatic symptoms exist → SSD, not IAD. IAD patients worry about disease, not about symptoms. |
| C | There is a high level of anxiety about health, and the individual is easily alarmed about personal health status [2] | Health anxiety is the engine driving the condition |
| D | The individual performs excessive health-related behaviours (e.g., repeatedly checks body for signs of illness) OR exhibits maladaptive avoidance (e.g., avoids doctor appointments and hospitals) [2] | Two subtypes: care-seeking type (excessive visits) vs care-avoidant type (phobic avoidance of medical settings). Both are maladaptive. |
| E | Illness preoccupation has been present for ≥6 months, but the specific illness feared may change [2] | The fear may shift (e.g., cancer → MS → ALS) but the underlying preoccupation persists |
| F | Not better explained by another mental disorder [2] | Must rule out SSD (if prominent somatic symptoms), GAD (if worry extends beyond health), OCD (if intrusive thoughts with rituals), BDD (if about appearance), delusional disorder (if delusional intensity) |
| Criterion | Requirement |
|---|---|
| (a) | Persistent belief in the presence of ≥1 serious physical illness underlying the presenting symptom(s), even though repeated investigations and examinations have identified no adequate physical explanation; OR a persistent preoccupation with a presumed deformity or disfigurement [2] |
| (b) | Persistent refusal to accept reassurance of several doctors [2] |
| Duration | ≥6 months [2] |
Note that ICD-10 hypochondriacal disorder is broader than DSM-5 illness anxiety disorder because it also includes preoccupation with perceived deformity (which DSM-5 would classify as BDD under OCD-related disorders).
DSM-5 Criteria (Functional Neurological Symptom Disorder, 300.11) [2]
| Criterion | Requirement | Explanation |
|---|---|---|
| A | ≥1 symptoms of altered voluntary motor or sensory function | The symptoms must be neurological in nature — motor (weakness, paralysis, movement disorders, gait abnormality, seizures) or sensory (anaesthesia, visual/hearing loss) |
| B | Clinical findings provide evidence of incompatibility between the symptom and recognised neurological or medical conditions | This is critical: there must be positive evidence of functional origin (e.g., Hoover's sign, distractibility of tremor, preserved optokinetic nystagmus in "blindness"), not merely absence of organic findings. The diagnosis is NOT made by exclusion alone. |
| C | The symptom or deficit is not better explained by another medical or mental disorder | Must rule out genuine neurological disease and other psychiatric conditions |
| D | The symptom or deficit causes clinically significant distress or impairment in functioning, or warrants medical evaluation | Functional impairment criterion |
DSM-5 Specifiers:
- With weakness or paralysis
- With abnormal movement (tremor, dystonia, myoclonus, gait disorder)
- With swallowing symptoms
- With speech symptoms (dysphonia, slurred speech)
- With attacks or seizures (psychogenic non-epileptic seizures/PNES)
- With anaesthesia or sensory loss
- With special sensory symptoms (visual, olfactory, hearing)
- With mixed symptoms
- With or without psychological stressor (DSM-5 no longer requires identification of a psychological stressor — this was removed because it was unreliable)
Critical Change from DSM-IV
DSM-IV required that the clinician judge the symptom to be "associated with psychological factors" and that a psychological stressor be identified. DSM-5 removed both requirements. The diagnosis now rests on positive neurological examination findings demonstrating incompatibility with disease, NOT on identifying a psychological cause. This was changed because (1) the psychological link was often assumed rather than demonstrated, and (2) requiring it biased against patients with genuine functional neurological symptoms who could not articulate a stressor.
| Criterion | Requirement |
|---|---|
| A | Preoccupation with ≥1 perceived defects or flaws in physical appearance that are not observable or appear slight to others [2] |
| B | At some point during the course, the individual has performed repetitive behaviours (mirror checking, excessive grooming, skin picking, reassurance seeking) or mental acts (comparing appearance with that of others) in response to the appearance concerns [2] |
| C | The preoccupation causes clinically significant distress or impairment |
| D | Not better explained by an eating disorder (concerns about body fat/weight → eating disorder, not BDD) |
Specifiers:
- With muscle dysmorphia (preoccupation with being insufficiently muscular)
- Insight specifier: good/fair, poor, absent/delusional [2]
| Criterion | Requirement | Explanation |
|---|---|---|
| A | Falsification of physical or psychological signs or symptoms, or induction of injury or disease, associated with identified deception [2] | The patient deliberately produces or fakes symptoms — this is the conscious element. However, the motivation is unconscious. |
| B | The individual presents themselves to others as ill, impaired, or injured | They want to be perceived as a patient |
| C | The deceptive behaviour is evident even in the absence of obvious external rewards [2] | No financial gain, no avoiding legal consequences — the gain is internal (assuming the sick role). If external gain is present → malingering, not factitious disorder. |
| D | Not better explained by another mental disorder (e.g., delusional disorder) |
Two subtypes:
- Factitious disorder imposed on self (Munchausen syndrome)
- Factitious disorder imposed on another (Munchausen syndrome by proxy / factitious disorder by proxy) — caretaker induces illness in someone under their care (e.g., parent → child). This is a form of child abuse [2].
The following comprehensive algorithm integrates the diagnostic approach from initial presentation to specific somatoform subtype diagnosis [2]:
Investigation Modalities
This is where clinical judgement is paramount. There are two competing risks [2]:
- Under-investigation → missing a genuine organic disease (SLE, MS, occult malignancy)
- Over-investigation → false-positive results leading to unnecessary invasive procedures, reinforcing illness behaviour, exposing patients to iatrogenic harm [2]
The guiding principle: investigations should be judicious and targeted based on the clinical presentation, not exhaustive or reflexive [2]. Each investigation should be ordered with a specific clinical question in mind.
These are ordered based on the symptom pattern, not as a blanket screening panel. The rationale for each is to exclude the most important mimics [2]:
| Symptom Pattern | Investigations | Rationale / Key Findings to Look For |
|---|---|---|
| Non-specific symptoms (fatigue, weight loss, malaise) | FBC, ESR/CRP, TFTs, fasting glucose/HbA1c, LFTs, RFTs, calcium/PTH, HIV serology, chest X-ray | FBC: anaemia (malignancy, chronic disease), lymphocytosis (infection). ESR/CRP: inflammatory markers elevated in SLE, infection, malignancy. TFTs: hypothyroidism causes fatigue; hyperthyroidism causes anxiety + weight loss. Calcium/PTH: hyperparathyroidism ("bones, stones, moans, groans"). |
| Pain-predominant (diffuse pain, headache, back pain, joint pain) | ESR/CRP, ANA, anti-dsDNA, complement, RF/anti-CCP, serum calcium, vitamin D, plain X-rays of affected areas | ANA elevated in SLE, Sjogren's, mixed connective tissue disease. RF/anti-CCP for rheumatoid arthritis. Vitamin D deficiency causes widespread musculoskeletal pain — common in Hong Kong due to indoor lifestyles. |
| GI symptoms (nausea, bloating, diarrhoea, abdominal pain) | FBC, coeliac serology (anti-tTG IgA), LFTs, stool studies, faecal calprotectin, consider OGD/colonoscopy if red flags | Coeliac disease is underdiagnosed. Faecal calprotectin distinguishes inflammatory bowel disease (elevated) from functional GI disorders (normal). Red flags for endoscopy: weight loss, rectal bleeding, anaemia, family history of GI malignancy, age > 50 with new symptoms. |
| Cardiovascular/respiratory (chest pain, palpitations, dyspnoea) | ECG, troponin (if acute), echocardiography, Holter monitor, chest X-ray, BNP/NT-proBNP, TFTs, pulmonary function tests | ECG: arrhythmias, ischaemic changes. Holter: paroxysmal arrhythmias. BNP: heart failure screen. TFTs: hyperthyroidism causes sinus tachycardia, AF. Always rule out PE in acute chest pain + dyspnoea (D-dimer, CTPA). |
| Neurological symptoms (weakness, sensory loss, seizures, movement disorders) | MRI brain/spine, EEG (especially video-EEG for seizures), nerve conduction studies/EMG, visual evoked potentials, lumbar puncture if indicated | MRI: demyelination (MS), space-occupying lesions. Video-EEG: gold standard for distinguishing epileptic seizures from psychogenic non-epileptic seizures (PNES) — normal EEG during the clinical event = functional. NCS/EMG: normal in FND (intact peripheral nerves + muscle). |
| Endocrine/metabolic mimics | TFTs, cortisol (AM or 24h urine free cortisol), plasma/urine metanephrines, glucose, calcium/PTH | Phaeochromocytoma: elevated plasma/urine metanephrines (episodic palpitations, hypertension, sweating — classic mimic of panic/somatoform). Cushing's: elevated cortisol (fatigue, weight gain, anxiety, depression). |
| Autoimmune/inflammatory screen | ANA, anti-dsDNA, complement (C3, C4), ESR, CRP, ANCA | Especially important in young women with multi-system complaints — SLE can mimic somatoform disorders for years before serological evidence appears. |
| Infection screen | HIV serology, hepatitis B/C serology, TB screening (IGRA/Mantoux), blood cultures if febrile | Relevant in Hong Kong: TB remains endemic; hepatitis B prevalence ~7.2% in general population; HIV incidence rising. |
These are not "investigations" in the traditional sense but are structured assessment instruments used to quantify and characterise the somatoform presentation:
| Tool | What It Measures | Clinical Utility |
|---|---|---|
| Patient Health Questionnaire-15 (PHQ-15) | Severity of 15 common somatic symptoms over past 4 weeks | Validated screening tool for somatic symptom burden. Scores: 0–4 minimal, 5–9 low, 10–14 medium, 15–30 high somatic symptom severity. Useful for monitoring treatment response. |
| Somatic Symptom Disorder — B Criteria Scale (SSD-12) | Cognitive, affective, and behavioural aspects of SSD (Criterion B) | 12-item self-report measuring the three DSM-5 Criterion B dimensions: cognitive (catastrophising), affective (health anxiety), behavioural (excessive health-related behaviours). |
| Whiteley Index (WI-7) | Health anxiety / hypochondriacal concerns | 7-item self-report screen for illness anxiety. Score ≥ 4 suggests significant health anxiety. |
| PHQ-9 | Depression severity | Screen for comorbid depression (30–60% comorbidity). Score ≥ 10 = moderate depression warranting treatment. |
| GAD-7 | Generalised anxiety severity | Screen for comorbid GAD. Score ≥ 10 = moderate anxiety. |
| Beck Depression Inventory (BDI) / Beck Anxiety Inventory (BAI) | Depression / anxiety symptom severity | Alternative validated scales for quantifying comorbid mood/anxiety symptoms |
| Structured Clinical Interview for DSM-5 (SCID-5) | Formal psychiatric diagnostic interview | Gold standard for confirming DSM-5 diagnoses including SSD, IAD, and comorbidities |
These are positive clinical signs that demonstrate incompatibility with recognised neurological disease — they are the "investigation" for FND, performed at the bedside [2]:
| Sign | How to Perform | What It Demonstrates | Why It Works |
|---|---|---|---|
| Hoover's sign (motor) | Place hand under the "weak" leg heel. Ask patient to flex the contralateral (strong) hip against resistance. | Involuntary extension of the "weak" leg occurs (pushing down on examiner's hand), but voluntary hip extension on the same side is "weak" | Contralateral hip flexion reflexively activates ipsilateral hip extensors via the crossed extensor reflex. If the motor pathway were truly damaged, this involuntary activation would also be absent. Its presence proves the pathway is structurally intact. |
| Tremor entrainment / distractibility (motor) | Ask the patient to copy a rhythmic tapping movement with the unaffected hand while you observe the tremor | Functional tremor changes frequency to match the tapping rhythm (entrainment) or stops entirely when attention is diverted | Organic tremor has a fixed frequency generated by a pathological oscillator (e.g., basal ganglia circuit in Parkinson's). It does not change with distraction. Functional tremor is generated by voluntary motor circuits and therefore competes with other voluntary tasks. |
| Drift without pronation (motor) | Arms outstretched, eyes closed, observe for drift | In functional weakness, the arm drifts downward but does NOT pronate. In UMN lesions, the arm pronates as it drifts (pronator drift) | UMN lesion preferentially weakens supinators → gravity + unopposed pronation. In functional weakness, the mechanism is different — no selective supinator weakness, so the arm falls without rotation. |
| Give-way weakness (motor) | Test power in a limb — the patient initially resists, then suddenly "gives way" | Inconsistent force output — initially normal power, then collapses | Organic weakness produces consistent, proportional weakness throughout the range. Give-way pattern suggests effort-dependent weakness. |
| Non-anatomical sensory loss (sensory) | Test light touch and pinprick across dermatomes | Sensory loss that splits exactly at the midline (nose, sternum, umbilicus) or does not follow dermatomal/peripheral nerve distributions | True sensory loss from a central lesion spares 1–2 cm around the midline (because midline skin has bilateral innervation from both hemispheres). Exact midline splitting is anatomically impossible with organic disease. |
| Tubular (tunnel) visual field (visual) | Test visual fields at 1 metre and then at 2 metres | The visual field remains the same size (tubular) at both distances | With organic lesions, the visual field expands proportionally with distance (like a cone). A fixed-size "tunnel" at all distances is geometrically impossible with real visual field loss. |
| Preserved optokinetic nystagmus (visual) | Pass an optokinetic drum/tape across the visual field of a "blind" patient | Nystagmus is present, proving the visual cortex is receiving and processing visual information | Optokinetic nystagmus requires an intact visual pathway from retina to occipital cortex. If the patient were truly cortically blind, no nystagmus would occur. |
| Video-EEG (seizures) | Continuous EEG monitoring during a clinical seizure event | Normal EEG during the clinical event | Epileptic seizures produce abnormal EEG activity (spikes, sharp waves, rhythmic discharges). Normal EEG during a seizure = psychogenic non-epileptic seizure (PNES). Additional features: eyes closed during event (eyes typically open in epilepsy), variable semiology, pelvic thrusting, prolonged duration > 2 min, no post-ictal confusion. |
FND Is a Positive Diagnosis, Not a Diagnosis of Exclusion
A very common mistake is to diagnose FND simply because MRI and blood tests are normal. This is wrong. FND requires positive examination findings demonstrating incompatibility with neurological disease (Criterion B of DSM-5). Normal investigations alone are insufficient. You must actively demonstrate signs like Hoover's, tremor entrainment, or non-anatomical sensory loss [2].
| Pitfall | Consequence | How to Avoid |
|---|---|---|
| Ordering blanket screening panels | False positives (e.g., mildly elevated ANA in a healthy person) → unnecessary follow-up, anxiety, invasive procedures | Target investigations to the clinical question. Ask: "What specific disease am I trying to exclude?" |
| Repeating previously normal investigations | Reinforces illness behaviour; does not provide lasting reassurance; wastes resources [2] | Review old records before ordering. One thorough workup is sufficient unless new symptoms emerge. |
| Investigating to "reassure" the patient | Paradoxically increases anxiety — negative results do NOT provide lasting reassurance in somatoform disorders [2] | Explain to the patient upfront that normal results are expected and are GOOD news, not evidence that "they haven't found it yet." |
| Missing incidental findings | Incidentalomas (adrenal, thyroid, renal, hepatic) trigger further workup that may never have been needed | Only order imaging with a clear indication. If incidental findings arise, follow established guidelines for their management, not the patient's anxiety. |
| Over-investigating in factitious disorder | The patient may actively interfere with samples, inject themselves with substances, or tamper with monitoring equipment | If factitious disorder is suspected, observe specimen collection, check for injection marks, consider toxicology screen, review records from other hospitals. |
High Yield Summary — Diagnosis
Somatic Symptom Disorder (DSM-5):
- Criterion A: ≥1 distressing somatic symptom (medically explained or not)
- Criterion B: Disproportionate thoughts (catastrophising), anxiety about health, OR excessive time/energy devoted to symptoms — at least ONE required
- Criterion C: Persistent state of being symptomatic, typically > 6 months
- Key difference from ICD-10: DSM-5 does NOT require symptoms to be medically unexplained; ICD-10 requires ≥2 years + no physical explanation + refusal of reassurance
Illness Anxiety Disorder (DSM-5):
- Preoccupation with having/acquiring serious illness + minimal/no somatic symptoms + ≥6 months
- Two subtypes: care-seeking vs care-avoidant
- If prominent somatic symptoms present → SSD, not IAD
Functional Neurological Symptom Disorder (DSM-5):
- Neurological symptoms with clinical evidence of INCOMPATIBILITY with recognised disease
- Requires POSITIVE signs (Hoover's, entrainment, non-anatomical sensory loss) — NOT just normal investigations
- No longer requires identified psychological stressor
Investigation Principles:
- Judicious and targeted, not exhaustive
- Each test must answer a specific clinical question
- False positives are dangerous — may trigger iatrogenic cascade
- Normal results do NOT reassure somatoform patients
- Review old records before repeating investigations
Active Recall - Diagnostic Criteria and Investigations for Somatoform Disorders
[2] Senior notes: ryanho-psych.md (Sections 8.4.1, 8.4.2.1, 8.4.2.2, 8.4.2.3 — Approach to MUS, Somatic Symptom Disorder diagnostic criteria, Illness Anxiety Disorder diagnostic criteria, Conversion disorder, Other Related Disorders)
Management of Somatoform Disorders
Before discussing specific treatment modalities, it is essential to understand why somatoform disorders are so difficult to manage and what the overarching treatment philosophy should be. Think about this from first principles:
The core problem in somatoform disorders is a self-reinforcing cycle: somatic symptoms → health anxiety → maladaptive behaviours (checking, doctor-shopping, avoidance) → reinforcement of illness beliefs → more somatic symptoms. Any management strategy must break this cycle at one or more points [2].
There are several unique challenges:
- Patients do not believe they have a psychiatric condition — their symptoms are real, and they feel genuinely ill. Telling them "it's all in your head" is both inaccurate and therapeutic poison.
- 70–90% of patients decline psychotherapy when offered [2] — therapeutic engagement is a major barrier.
- The healthcare system can reinforce the problem — each new investigation, each new specialist opinion, each prescription of an analgesic perpetuates the cycle [2].
- Comorbid psychiatric conditions (depression 30–60%, anxiety disorders, substance use) must be addressed simultaneously, as they maintain the somatoform symptoms [2].
- Course is chronic and fluctuating — 50–75% improve but rarely fully resolve [2]. The realistic goal is functional improvement and reduced distress, not "cure."
The Cardinal Rule of Management
The therapeutic relationship IS the treatment. In somatoform disorders, the single most important intervention is building a trusting, consistent, non-dismissive relationship with the patient. Without this, no amount of CBT or SSRI will work. The patient must feel heard, believed, and respected before they will accept a biopsychosocial explanation for their symptoms [2].
The approach differs slightly depending on which somatoform subtype is being managed:
| Condition | First-Line | Second-Line | Third-Line |
|---|---|---|---|
| Somatic Symptom Disorder | Reassurance + psychoeducation ± treatment of comorbidities [2] | CBT (targeting health beliefs and expectations) + relaxation training [2] | Antidepressants (SSRI, SNRI, low-dose TCAs) if comorbid anxiety/depressive/OC disorder [2] |
| Illness Anxiety Disorder | CBT (1st line): cognitive restructuring for maladaptive illness cognitions + ERP for maladaptive checking behaviours + psychoeducation [2] | Other psychotherapy (2nd line): e.g., mindfulness-based cognitive therapy [2] | Antidepressants (3rd line): SSRI, SNRI [2] |
| Functional Neurological Symptom Disorder | Reassurance + psychoeducation (1st line) [2] | Physical therapy for motor symptoms; CBT for other symptoms (2nd line) [2] | Address psychiatric comorbidities (depression, anxiety, personality disorders) |
| Body Dysmorphic Disorder | CBT (with ERP components) + high-dose SSRI | Augmentation with antipsychotics if delusional BDD | Referral for specialised BDD treatment; avoid cosmetic surgery (generally worsens outcomes) |
Detailed Treatment Modalities
This is universally the first step for ALL somatoform disorders. It is not merely "being nice" — it is a structured therapeutic intervention [2].
Basic approaches to medically unexplained symptoms [2]:
| Principle | What to Do | Why It Works |
|---|---|---|
| Emphasise that the symptoms are real and familiar to the clinician [2] | "I can see these symptoms are causing you genuine suffering. I see patients with similar problems regularly." | Validates the patient's experience. Reduces defensive posture. Builds trust. If the patient feels dismissed, they will disengage and continue doctor-shopping. |
| Explain the role of psychosocial factors in ALL medical conditions [2] | "Stress affects every part of the body — it can change your heart rate, digestion, pain thresholds, muscle tension. This happens to everyone." | Normalises the mind-body connection without pathologising the patient. Uses examples they can relate to (e.g., "butterflies in the stomach before an exam"). |
| Offer and discuss a psychosocial explanation of the symptoms [2] | "It seems like the stress from your work/family situation may be amplifying the signals your body is sending." | Provides a coherent explanatory model. The patient needs an ALTERNATIVE narrative to replace "I must have cancer." |
| Allow adequate time for the patient and partner/family to ask questions [2] | Unhurried consultations; involve family if appropriate | Rushing reinforces the patient's fear that they are being dismissed |
| Agree a treatment plan including [2]: | (1) Treatment of any minor medical problem contributing; (2) Treatment of any comorbid psychiatric disorder; (3) Graded activity to improve fitness; (4) Diary keeping to explore symptom-psychosocial links [2] | Collaborative goal-setting empowers the patient and shifts them from passive illness behaviour to active self-management |
Scheduled Appointments — A Key Strategy
A crucial management principle is switching from symptom-driven appointments to time-contingent (scheduled) appointments. Instead of the patient coming to the clinic whenever symptoms worsen (which reinforces the link between symptoms and medical attention), arrange regular follow-ups at fixed intervals (e.g., every 2–4 weeks) regardless of symptom status. This breaks the contingency between symptom → medical attention and provides consistent support without reinforcing illness behaviour.
Relaxation techniques directly target the physiological arousal (sympathetic overdrive) that produces many somatic symptoms [2]:
| Technique | How It Works | Indications |
|---|---|---|
| Progressive muscle relaxation (PMR) [2] | Systematic tensing and releasing of muscle groups → reduces chronic muscle tension → reduces tension-type headaches, back pain, myofascial pain | Particularly useful when somatic symptoms are pain-predominant or tension-related |
| Diaphragmatic breathing [2] | Slow, deep breathing activates the parasympathetic nervous system (vagal tone) → reduces heart rate, lowers BP, reduces hyperventilation-related symptoms (dizziness, tingling, chest tightness) | Particularly useful when symptoms include palpitations, dyspnoea, dizziness, paraesthesiae |
| Mindfulness meditation | Non-judgemental awareness of present-moment experience → reduces ruminative worry about health → breaks the "monitoring → catastrophising" cycle | Can be self-guided or therapist-led. Useful as an adjunct to CBT. |
| Biofeedback | Real-time physiological data (heart rate, muscle tension, skin conductance) is fed back to the patient → teaches them to consciously regulate these parameters | Provides objective evidence to the patient that they CAN influence their bodily sensations |
C. Cognitive Behavioural Therapy (CBT) [2]
CBT is the mainstay formal psychotherapy for somatoform disorders [1][2]. It directly targets the cognitive and behavioural factors that maintain the disorder.
| CBT Component | Technique | What It Targets | Example |
|---|---|---|---|
| Cognitive restructuring | Identify and challenge dysfunctional automatic thoughts about health [2] | Maladaptive illness beliefs ("headache = brain tumour") | "What is the actual probability that a headache in a 30-year-old with normal examination represents a brain tumour? What are the 10 most common causes of headache?" |
| Behavioural experiments | Test predictions about feared outcomes in real life | Catastrophic predictions ("if I don't check my pulse every hour, I'll miss a heart attack") | "Let's try not checking your pulse for one day. What do you predict will happen? What actually happened?" |
| Exposure and response prevention (ERP) | Systematic exposure to anxiety-provoking health-related stimuli while preventing the maladaptive response [2] | Compulsive checking behaviours, reassurance-seeking, avoidance | Gradually reduce the number of daily BP checks from 20 to 10 to 5 to 2 to 1. Resist the urge to Google symptoms for progressively longer intervals. |
| Psychoeducation [2] | Educate about the role of attention, anxiety, and arousal in symptom perception | The amplification model — why monitoring symptoms makes them worse | "Imagine I asked you to pay attention to your left big toe right now. Can you feel it? Now you're aware of sensations you weren't noticing before. This is what happens when you constantly monitor your body." |
| Activity scheduling/graded activity | Progressive increase in physical and social activity [2] | Deconditioning and avoidance that perpetuate disability | Start with 5 minutes of walking, increase by 5 minutes per week. The improvement in physical capacity provides corrective evidence against illness beliefs. |
- Somatic symptom disorder: CBT is the most evidence-based psychotherapy. Meta-analyses show moderate effect sizes (d ≈ 0.4–0.6) for reducing somatic symptom severity, health anxiety, and healthcare utilisation.
- Illness anxiety disorder: CBT is first-line [2]. Cognitive restructuring targets the maladaptive cognitive processes maintaining illness preoccupation; ERP targets maladaptive checking behaviours [2].
- FND: CBT is effective for non-motor symptoms; physiotherapy is preferred for motor symptoms [2].
The 70–90% Problem
70–90% of patients with somatic symptom disorder decline psychotherapy when offered [2]. This is a major practical barrier. Reasons include: (1) patients feel the referral implies their symptoms are "not real"; (2) stigma around seeing a psychologist/psychiatrist; (3) preference for a medical/physical explanation. Strategies to improve uptake: frame CBT as "learning to manage symptoms better" rather than "treating a mental problem"; integrate psychological services within the medical clinic (collaborative care model); use digital/online CBT as a less stigmatising entry point.
| Modality | Mechanism | Indication | Evidence |
|---|---|---|---|
| Mindfulness-based cognitive therapy (MBCT) [2] | Combines mindfulness meditation with cognitive therapy. Teaches non-judgemental awareness of bodily sensations without catastrophic interpretation. Breaks the "sensation → automatic thought → anxiety" chain. | Second-line for illness anxiety disorder [2]. Useful when CBT alone is insufficient or when rumination is a major feature. | Growing evidence base; originally developed for relapse prevention in depression but increasingly applied to health anxiety |
| Psychodynamic psychotherapy [2] | Explores unconscious conflicts, developmental experiences, and relational patterns that may underlie somatisation. Based on the classical conversion model — understanding why distress is expressed through the body. | Patients with identifiable interpersonal/developmental themes (e.g., childhood abuse, insecure attachment). Patients who are psychologically-minded and motivated for self-exploration. | Moderate evidence; may be helpful when CBT is ineffective or declined |
| Supportive psychotherapy [1][2] | Provides a consistent, empathic therapeutic relationship. Focus on coping strategies, problem-solving, and emotional support rather than symptom resolution. | All patients — forms the basis of the therapeutic relationship. Particularly useful when patients are not ready for structured CBT. | Universal component of care |
| Interpersonal therapy (IPT) | Focuses on interpersonal difficulties (grief, role disputes, role transitions, interpersonal deficits) that contribute to distress | When somatisation appears driven by interpersonal stressors | Limited but emerging evidence |
E. Pharmacotherapy [1][2]
Pharmacotherapy in somatoform disorders is adjunctive — it is not the primary treatment but plays an important role, especially when comorbid psychiatric conditions are present [2].
| Indication | Rationale |
|---|---|
| Comorbid depression (30–60%) | Depression amplifies somatic symptom perception and maintains health anxiety. Treating depression often reduces somatic symptom burden. |
| Comorbid anxiety disorders (GAD, panic, OCD) | Anxiety drives the hypervigilance-catastrophising-checking cycle. Reducing anxiety breaks this cycle. |
| Illness anxiety disorder (3rd line) [2] | When CBT and other psychotherapy are insufficient or declined |
| Somatic symptom disorder with predominant pain | Antidepressants have independent analgesic properties (SNRIs, TCAs) beyond their mood effects |
1. SSRIs (Selective Serotonin Reuptake Inhibitors) [1][2]
- Mechanism: Block the serotonin transporter (SERT) → increase synaptic 5-HT availability → downstream effects on amygdala reactivity (reduced fear/anxiety), anterior cingulate function (improved emotional regulation), and descending pain modulation pathways (reduced pain perception)
- Examples: paroxetine, citalopram, escitalopram, fluoxetine, sertraline, fluvoxamine [1]
- First-line pharmacotherapy for somatoform disorders with comorbid anxiety/depression [2]
- Onset of action: 2–4 weeks (important to counsel patients — they may become frustrated if expecting immediate relief)
- Initial worsening: Most SSRIs cause increased anxiety symptoms (apprehension, sleeplessness, palpitations) in the first 1–2 weeks [2] — this is particularly problematic in somatoform patients who are already hypersensitive to bodily sensations. Start low, go slow.
- Duration: Usually maintained for ≥6 months to prevent relapse [2]
- Adverse effects: GI disturbance (nausea, diarrhoea), sexual dysfunction, headache, insomnia/somnolence, weight changes, serotonin syndrome (if combined with other serotonergic agents), hyponatraemia (especially elderly — SIADH mechanism), increased bleeding risk (serotonin-mediated platelet dysfunction)
- Contraindications/cautions: Concurrent MAOIs (serotonin syndrome risk), active GI bleeding, pregnancy (particularly paroxetine — category D), bipolar disorder (risk of manic switch)
2. SNRIs (Serotonin-Noradrenaline Reuptake Inhibitors) [1][2]
- Mechanism: Block both SERT and the noradrenaline transporter (NET) → dual monoamine enhancement. The noradrenergic component adds to efficacy in pain syndromes (descending noradrenergic pain inhibition pathways in the spinal cord) and fatigue.
- Examples: venlafaxine, duloxetine [1]
- Indications: Particularly useful when somatic symptom disorder is associated with predominant pain (duloxetine has specific evidence for fibromyalgia, diabetic neuropathic pain, chronic musculoskeletal pain) or when SSRI response is inadequate
- Adverse effects: Similar to SSRIs plus: hypertension (noradrenergic effect — must monitor BP), more pronounced discontinuation syndrome (especially venlafaxine — must taper slowly), sweating
- Contraindications/cautions: Uncontrolled hypertension, concurrent MAOIs, hepatic impairment (duloxetine)
3. Low-dose Tricyclic Antidepressants (TCAs) [1][2]
- Mechanism: Block SERT and NET (like SNRIs) but also block muscarinic, histaminic, and α-adrenergic receptors — these additional actions produce side effects but also contribute to sedation (useful in insomnia) and analgesia
- Examples: Amitriptyline (most commonly used at low dose for pain), imipramine, clomipramine
- Imipramine — particularly for panic disorder [1]; clomipramine — particularly for OCD [1]
- Use in somatoform disorders: Low-dose amitriptyline (10–50 mg nocte) is widely used for chronic pain syndromes, fibromyalgia, and functional GI disorders (e.g., IBS). At these doses, the antidepressant effect is minimal — the benefit is primarily analgesic (via descending pain pathway modulation) and sedative (via H1 antagonism)
- Adverse effects: Anticholinergic (dry mouth, constipation, urinary retention, blurred vision), sedation, weight gain, orthostatic hypotension, cardiac conduction abnormalities (QT prolongation, heart block) — dangerous in overdose (cardiac arrhythmias, seizures)
- Contraindications: Recent MI, heart block, mania, severe hepatic impairment, concurrent MAOIs. Dangerous in overdose — avoid prescribing large quantities to patients at suicide risk
Why Start Low, Go Slow in Somatoform Patients?
Somatoform patients have an amplifying perceptual style — they are hyper-attentive to bodily sensations. SSRI/SNRI initiation commonly causes transient GI symptoms, palpitations, and increased anxiety. In a normal patient, these are minor and tolerable. In a somatoform patient, they can be terrifying and interpreted as evidence of serious disease, leading to immediate discontinuation and further loss of trust in medical treatment. Therefore: start at half the usual starting dose and increase gradually with careful counselling about expected initial side effects [2].
4. Benzodiazepines [1]
- Effective anxiolytics but only for SHORT-TERM use (not more than 1 month) [1]
- Mechanism: Positive allosteric modulators of GABA-A receptors → increase chloride channel opening frequency → neuronal inhibition → anxiolytic, sedative, muscle relaxant, anticonvulsant effects
- Role in somatoform disorders: Very limited. May provide short-term relief during acute crises but carry significant risks of dependence, tolerance, and withdrawal — all of which are particularly problematic in somatoform patients who are already at risk of substance use disorders [2]
- Risks: Dependence (can develop within 2–4 weeks of regular use), tolerance, withdrawal symptoms (anxiety, insomnia, tremor, seizures), sedation, cognitive impairment, falls (elderly), respiratory depression
- Contraindications: Respiratory failure, severe hepatic impairment, myasthenia gravis, sleep apnoea, history of substance use disorder
Benzodiazepines in Somatoform Disorders — A Trap
Prescribing benzodiazepines for somatoform patients is a common pitfall. The short-term relief they provide reinforces medication-seeking behaviour, and the patient quickly develops tolerance → dose escalation → dependence. Substance use disorders are already a recognised complication of somatoform disorders (patients self-medicate with narcotic analgesics and benzodiazepines) [2]. Prescribing benzodiazepines can turn a chronic somatoform disorder into a chronic somatoform disorder PLUS benzodiazepine dependence.
5. Other Pharmacological Agents
| Agent | Mechanism | Role in Somatoform Disorders | Notes |
|---|---|---|---|
| Beta-adrenergic antagonists (e.g., propranolol) [1] | Block peripheral β-adrenergic receptors → reduce heart rate, tremor, sweating | Useful for peripheral autonomic symptoms of anxiety (palpitations, tremor, sweating) but does NOT address central anxiety or health cognitions | Does not treat the underlying disorder; only masks peripheral symptoms. Useful as adjunct for performance-related somatic symptoms. |
| Buspirone [1] | 5-HT₁A partial agonist → SSRI-like effect. Onset of action ~4 weeks. Does NOT cause sedation [2] | Effective in GAD but NOT in other anxiety disorders [2]. Limited role in somatoform disorders specifically, but may be helpful when GAD is comorbid. | Advantage: no sedation, no dependence. Disadvantage: slow onset, limited spectrum. |
| Pregabalin [1] | Binds α₂δ subunit of presynaptic voltage-dependent Ca²⁺ channels → blocks release of excitatory neurotransmitters (glutamate) | Useful when comorbid GAD and/or neuropathic pain. Licensed for GAD and neuropathic pain. | Side effects: somnolence, dizziness, weight gain. Caution: potential for misuse/dependence (Schedule V in US). |
| Antipsychotics (low-dose) [1] | Various receptor profiles depending on agent | Very limited role — only if beliefs reach delusional intensity (somatic delusional disorder) or as augmentation for severe treatment-resistant BDD | Not first-line for any somatoform disorder |
FND requires a distinct management approach because the symptom type (neurological) demands specific rehabilitation strategies [2]:
| Step | Intervention | Rationale |
|---|---|---|
| Step 1 | Reassurance and psychoeducation (1st line) [2] | Explaining the diagnosis clearly is the single most therapeutic intervention. Name the condition ("functional neurological symptom disorder"), explain that it is common and genuine, show the patient their own positive signs (e.g., demonstrate Hoover's sign to them), and explain that the nervous system is "not damaged but is sending incorrect signals — like a software problem, not a hardware problem." |
| Step 2a | Physical therapy for motor symptoms (2nd line) [2] | Evidence-based physiotherapy for FND uses motor retraining, gait re-education, and graded exercise. The physiotherapist works to re-establish normal movement patterns by redirecting attention away from the affected limb (exploiting distractibility). |
| Step 2b | CBT for other symptoms (2nd line) [2] | Targets the cognitive and emotional factors maintaining non-motor FND symptoms (dissociative symptoms, pain, fatigue, cognitive symptoms) |
| Step 3 | Treat psychiatric comorbidities [2] | Up to 90% have psychiatric comorbidity: depression (32%), GAD (21%), panic disorder (36%), dissociation (47%), personality disorders [2]. These maintain the functional symptoms and must be addressed. |
Do Not Reinforce FND Symptoms
Symptoms in FND can be reinforced by treatment measures [2]. For example, providing a wheelchair to a patient with functional leg weakness may entrench the symptom by removing any incentive or opportunity for the motor system to "re-engage." Similarly, excessive bed rest, walking aids, and mobility equipment should be avoided unless absolutely necessary. The rehabilitation approach should be activating, not accommodating.
Management is difficult due to chronic recurrent course [2]:
| Line | Treatment | Details |
|---|---|---|
| 1st line | CBT [2] | Cognitive restructuring to address maladaptive cognitive processes maintaining illness preoccupation; ERP to address maladaptive checking/reassurance-seeking behaviours; psychoeducation about the attention-amplification cycle [2] |
| 2nd line | Other psychotherapy [2] | e.g., mindfulness-based cognitive therapy (MBCT) [2] — teaches non-judgemental awareness of bodily sensations without reactive catastrophising |
| 3rd line | Antidepressants [2] | SSRI, SNRI [2] — when psychotherapy is insufficient, declined, or when significant comorbid anxiety/depression is present |
| Principle | Implementation | Why It Matters |
|---|---|---|
| Single primary clinician | Designate one doctor (usually GP) as the primary contact. All referrals and investigations go through this person. | Prevents doctor-shopping, conflicting advice, and unnecessary duplication of investigations |
| Scheduled (time-contingent) visits | Regular appointments regardless of symptom status (e.g., every 2–4 weeks initially) | Breaks the reinforcement loop between symptoms → medical consultation. Provides consistent support. |
| Limit investigations | No further investigations unless new clinical features emerge that warrant specific evaluation [2] | Prevents false-positive cascades and iatrogenic harm. Reassurance from normal results is transient in these patients [2]. |
| Avoid iatrogenic harm | Minimise narcotic analgesics, benzodiazepines, unnecessary procedures [2] | Substance use disorders and iatrogenic surgical complications are recognised complications [2] |
| Treat the whole person | Address sleep, diet, exercise, social isolation, occupational functioning, family dynamics | Deconditioning, social withdrawal, and occupational disability perpetuate the illness cycle |
| Set realistic expectations | "The goal is to live well WITH your symptoms, not to eliminate them entirely" | Prevents frustration and therapeutic rupture when symptoms inevitably fluctuate |
| Collaborative care model | Integrate psychiatry, psychology, physiotherapy, and primary care within a shared management plan | Evidence shows better outcomes than sequential referral between disconnected services |
Referral to secondary care (specialist psychiatric services) should be considered when [2]:
- Risk of self-harm or suicide
- Marked self-neglect
- Non-response to at least two treatments (e.g., psychoeducation + SSRI, or psychoeducation + CBT)
- Significant comorbidity (e.g., substance use, severe personality disorder, psychotic features)
- Diagnostic uncertainty (e.g., concern about delusional disorder, somatic subtype)
- Factitious disorder or suspected malingering
| Condition | 1st Line | 2nd Line | 3rd Line | Key Pitfalls |
|---|---|---|---|---|
| SSD | Reassurance + psychoeducation + treat comorbidities [2] | CBT + relaxation training [2] | Antidepressants (SSRI/SNRI/low-dose TCA) [2] | 70–90% decline psychotherapy [2]; avoid BZDs and opioids |
| IAD | CBT (cognitive restructuring + ERP) [2] | MBCT [2] | Antidepressants (SSRI/SNRI) [2] | Chronic course; repeated reassurance is counterproductive |
| FND | Reassurance + psychoeducation [2] | Physiotherapy (motor) / CBT (other) [2] | Treat comorbidities | Do not reinforce symptoms with aids/accommodations |
| BDD | CBT + high-dose SSRI | Antipsychotic augmentation if delusional | Specialised BDD treatment | Cosmetic surgery generally worsens outcomes |
High Yield Summary — Management
Foundation (ALL somatoform disorders):
- Therapeutic relationship is the treatment
- Emphasise symptoms are real; explain psychosocial factors; offer biopsychosocial explanation
- Scheduled appointments, single clinician, limit investigations
- Treat comorbid depression/anxiety (SSRI + CBT)
Psychotherapy:
- CBT is first-line formal psychotherapy for all somatoform subtypes
- Targets: dysfunctional health beliefs (cognitive restructuring), maladaptive behaviours (ERP/behavioural experiments), psychoeducation (attention-amplification model)
- 70–90% decline psychotherapy — engagement is the biggest barrier
- MBCT is second-line, especially for IAD
Pharmacotherapy:
- SSRIs first-line (start low, go slow — amplifying perceptual style makes patients hypersensitive to side effects)
- SNRIs useful for pain-predominant presentations (duloxetine for fibromyalgia/chronic pain)
- Low-dose TCAs (amitriptyline) for chronic pain and insomnia
- BZDs: SHORT-TERM only (max 1 month), high risk of dependence — avoid in somatoform disorders
- Propranolol for peripheral autonomic symptoms only
FND-specific:
- Psychoeducation (1st line) → Physiotherapy for motor / CBT for other symptoms (2nd line)
- Do NOT reinforce symptoms with wheelchair/mobility aids
Key Pitfalls:
- Never tell patients "it's all in your head"
- Never prescribe long-term benzodiazepines or opioids
- Never order investigations to "reassure" — it doesn't work
- Never provide mobility aids without active rehabilitation plan for FND
Active Recall - Management of Somatoform Disorders
References
[1] Lecture slides: GC 167. I feel very nervous Anxiety disorders.pdf (p36–37, treatment of anxiety disorders, antidepressant classes) [2] Senior notes: ryanho-psych.md (Sections 8.4.1, 8.4.2.1, 8.4.2.2, 8.4.2.3 — management of MUS, somatic symptom disorder, illness anxiety disorder, conversion disorder, other related disorders; Section 3.1.1 antidepressants; Section 3.1.4 benzodiazepines and anxiolytics; Section 3.3 psychotherapy)
Complications of Somatoform Disorders
Complications in somatoform disorders are particularly insidious because they arise not only from the disease itself but — critically and often predominantly — from the healthcare system's response to the patient. Many complications are iatrogenic (Greek: iatros = physician, genic = caused by) — literally "caused by the doctor." Understanding this is essential because it means that how you manage these patients directly determines their complication risk.
The complications can be organised into six domains:
- Iatrogenic complications from unnecessary investigations and procedures
- Substance use disorders
- Psychiatric comorbidity and its consequences
- Functional impairment and disability
- Impact on the healthcare system
- Condition-specific complications
This is the single most important category of complications and the one most directly under the clinician's control [2].
Why Does This Happen?
The mechanism unfolds like this: the patient presents with persistent somatic complaints → the clinician, uncertain about the diagnosis or pressured by the patient's distress, orders investigations → investigations are negative → the patient is not reassured (this is a core feature of the disorder — repeated negative workups do NOT alleviate fears) [2] → the patient seeks further opinions → another clinician orders more investigations → some yield false-positive or incidental findings → these trigger further, more invasive workup → the cascade continues.
Each step in this cascade carries risk:
| Iatrogenic Risk | Mechanism | Examples |
|---|---|---|
| False-positive results | Every test has a false-positive rate. In a low-prevalence population (i.e., patients without organic disease), the positive predictive value of any test drops dramatically. Ordering many tests in someone unlikely to have disease means many false positives [2]. | Mildly elevated ANA in a healthy individual → rheumatology referral → further immunological testing → joint aspiration → none of which was needed. CT incidentaloma → biopsy → haemorrhage. |
| Incidental findings | Cross-sectional imaging (CT, MRI) frequently reveals incidental findings (adrenal nodules, renal cysts, thyroid nodules, lung nodules) that have nothing to do with the patient's symptoms but trigger protocolised follow-up | CT abdomen for "abdominal pain" finds a 1.5 cm adrenal incidentaloma → interval imaging, possibly adrenal vein sampling, biochemical workup — all for a benign non-functioning adenoma in someone whose pain was functional |
| Procedural complications | Invasive procedures carry inherent risks of bleeding, infection, perforation, anaesthetic complications | Unnecessary exploratory laparotomy → post-operative adhesions → bowel obstruction. Repeated endoscopy → perforation. Unnecessary cardiac catheterisation → vascular access site complications, contrast nephropathy. Unnecessary lumbar puncture → post-LP headache, spinal haematoma. |
| Radiation exposure | Repeated CT scans and fluoroscopic procedures deliver cumulative ionising radiation | Lifetime cancer risk increases with cumulative radiation dose. Patients who have had 10+ CT scans for recurrent "abdominal pain" or "chest pain" have received meaningful radiation exposure. |
| Contrast reactions | Iodinated CT contrast and gadolinium MRI contrast carry risks | Anaphylactoid reactions, contrast-induced nephropathy (iodinated contrast in patients with borderline renal function), nephrogenic systemic fibrosis (gadolinium in renal impairment) |
| Surgical complications | Patients with chronic somatic complaints, particularly pain, may undergo elective surgeries that are unlikely to help | Unnecessary hysterectomy for chronic pelvic pain, unnecessary cholecystectomy for functional dyspepsia, unnecessary appendicectomy for right iliac fossa pain — all with standard surgical risks (wound infection, DVT/PE, adhesions) and NO symptom improvement because the underlying cause was somatoform |
The Surgical Trap
A particularly dangerous pattern occurs when surgeons operate on somatoform patients for pain complaints. The surgery does not relieve the pain (because the pain's origin is central sensitisation and amplified perception, not a structural lesion). The patient then has post-operative pain ON TOP of their original functional pain, plus adhesions from the surgery that may cause genuine organic pain in the future. The net result is a worse outcome than before surgery. Chronic pelvic pain and chronic abdominal pain are the most common contexts for this.
Substance use disorders in attempt to manage distress are a recognised complication [2]. The substances most commonly implicated are narcotic analgesics and benzodiazepines [2].
Why Does This Happen?
Think about it from the patient's perspective: they are in genuine distress, their symptoms are real and debilitating, and no one has provided an adequate explanation or effective treatment. When a clinician prescribes an opioid for "pain" or a benzodiazepine for "anxiety," the patient experiences rapid relief — perhaps the first effective relief they have had. This creates a powerful reinforcement loop:
| Step | What Happens | Mechanism |
|---|---|---|
| 1 | Patient has chronic somatic symptoms (pain, anxiety) | Central sensitisation, amplified perception, autonomic arousal |
| 2 | Clinician prescribes opioid/benzodiazepine | Rapid symptom relief via mu-opioid receptor agonism (pain modulation) or GABA-A potentiation (anxiolysis) |
| 3 | Patient experiences relief | Positive reinforcement — the drug "works" |
| 4 | Tolerance develops | Neuroadaptation: receptor downregulation, reduced endogenous opioid/GABA tone |
| 5 | Dose escalation required for same effect | The patient seeks higher doses or more frequent prescriptions |
| 6 | Dependence develops | Physical dependence (withdrawal symptoms if drug is stopped) + psychological dependence (drug-seeking behaviour) |
| 7 | Withdrawal symptoms mimic/worsen the original somatic symptoms | Opioid withdrawal: pain, nausea, diarrhoea, myalgia. BZD withdrawal: anxiety, insomnia, tremor, seizures. These symptoms are indistinguishable from the patient's original complaints. |
| 8 | Patient is now worse than before | Original somatoform disorder + iatrogenic substance dependence + withdrawal-related symptom amplification |
Specific substance risks:
| Substance | Why Patients Seek It | Specific Risks |
|---|---|---|
| Opioid analgesics (codeine, tramadol, oxycodone, morphine) [2] | Chronic pain complaints; doctor-shopping for prescriptions | Opioid use disorder, opioid-induced hyperalgesia (paradoxically worsens pain over time), respiratory depression, constipation, cognitive impairment, overdose death |
| Benzodiazepines (diazepam, alprazolam, clonazepam, lorazepam) [2] | Anxiety, insomnia, panic symptoms | BZD dependence, cognitive impairment, falls (especially elderly), withdrawal seizures (can be life-threatening), rebound anxiety worse than the original |
| Alcohol | Self-medication for anxiety, insomnia, and pain | Alcohol use disorder, liver disease, GI haemorrhage, interactions with prescribed medications, withdrawal (delirium tremens) |
| Over-the-counter analgesics (paracetamol, NSAIDs) | Chronic pain; easily accessible without prescription | Paracetamol hepatotoxicity (especially with chronic supratherapeutic dosing), NSAID gastropathy (peptic ulcers, GI bleeding), NSAID nephrotoxicity |
Somatoform disorders have extremely high rates of psychiatric comorbidity, and these comorbid conditions are complications in their own right — they worsen outcomes, complicate treatment, and introduce additional risks [2].
| Comorbid Condition | Prevalence | Why It Complicates Somatoform Disorders |
|---|---|---|
| Major Depressive Disorder | 30–60% comorbid with SSD [2]; 43% with IAD [2] | Depression amplifies somatic symptom perception (depressed patients have lower pain thresholds), reduces motivation for treatment engagement, introduces suicide risk, worsens functional impairment. Somatic symptoms of depression (fatigue, sleep disturbance, appetite change) overlap with and are difficult to separate from the somatoform symptoms. |
| Generalised Anxiety Disorder | 71% comorbid with IAD [2]; common with SSD | Anxiety drives the hypervigilance-catastrophising-checking cycle that perpetuates somatoform symptoms. GAD adds worry about non-health domains, broadening the patient's overall burden. |
| Panic Disorder | 36% comorbid with FND [2]; 17% with IAD [2] | Panic attacks produce dramatic somatic symptoms (chest pain, dyspnoea, palpitations) that are indistinguishable from the somatoform symptoms — each panic attack reinforces the patient's belief that something is physically wrong. |
| Dissociative Disorders | 47% comorbid with FND [2] | Dissociation impairs self-awareness and insight, making it harder for the patient to engage with psychological models of their symptoms. Dissociative episodes may be mistaken for neurological events. |
| Personality Disorders | 77% comorbid with IAD [2]; common with FND (borderline, histrionic, narcissistic) [2] | Personality pathology makes the therapeutic relationship extremely challenging — borderline patients may split between clinicians, histrionic patients may dramatise symptoms, narcissistic patients may refuse to accept a non-organic explanation. Treatment dropout rates are high. |
| Substance Use Disorders | 17% with IAD [2]; risk factor in SSD [2] | As discussed above — creates a dual-diagnosis problem requiring simultaneous management |
| Dysthymia | 45% comorbid with IAD [2] | Chronic low-grade depression that perpetuates hopelessness and treatment non-engagement |
Suicide Risk
This is an under-appreciated complication. While somatoform disorders per se are not typically associated with high suicide rates, the comorbid depression and personality disorders introduce significant risk. Body dysmorphic disorder stands out with ~80% lifetime risk of suicidal ideation and ~25% attempting suicide [2]. Chronic suffering, functional impairment, social isolation, and perceived hopelessness all contribute.
Somatoform disorders cause profound functional impairment that extends across all domains of life:
| Domain | How Somatoform Disorders Cause Impairment | Downstream Consequences |
|---|---|---|
| Occupational | Chronic symptoms (pain, fatigue, dizziness) → reduced work capacity → frequent sick leave → unemployment | Loss of income, loss of professional identity, financial stress → worsens psychological distress → worsens symptoms (vicious cycle) |
| Social | Health preoccupation dominates conversations → social withdrawal → friends and family become frustrated or dismissive → isolation | Social isolation is a powerful risk factor for depression, which in turn worsens somatic symptoms. Family members may develop "carer fatigue." |
| Interpersonal/Familial | The patient's chronic illness behaviour strains relationships → marital conflict, parenting difficulties, dependency on family | ICD-10 criterion (c) specifically requires impairment of social and family functioning [2]. Family members may inadvertently reinforce illness behaviour (excessive concern, doing everything for the patient). |
| Physical deconditioning | Pain/fatigue → avoidance of physical activity → progressive deconditioning → reduced exercise tolerance → more fatigue and pain | Physical deconditioning creates a genuine physiological basis for symptoms that initially had no organic cause. Muscles atrophy, cardiovascular fitness declines, joints stiffen. This makes rehabilitation harder over time. |
| Financial | Multiple medical consultations, investigations, procedures, medications → high out-of-pocket costs; unemployment → reduced income | Financial stress is both a consequence and a perpetuating factor |
The Deconditioning Trap
One of the most pernicious complications is the deconditioning spiral. The patient initially has functional pain → avoids exercise → loses muscle mass and cardiovascular fitness → now genuinely has exercise intolerance and muscular weakness → this "confirms" their belief that something is physically wrong → more avoidance → more deconditioning. Breaking this cycle with graded activity is one of the most important therapeutic interventions, but it must be done early before severe deconditioning sets in.
While this is not a "complication for the patient" per se, the healthcare system burden is so substantial that it warrants mention — and it indirectly harms these patients by consuming resources and generating clinician frustration.
| Impact | Mechanism |
|---|---|
| High healthcare utilisation | Doctor-shopping, multiple specialist consultations, repeated investigations, emergency department presentations [2] |
| Clinician frustration and burnout | Patients who repeatedly present with unexplained symptoms and are not reassured by negative results can be demoralising for clinicians → risk of dismissive attitudes, rupture of therapeutic relationship |
| Opportunity cost | Time and resources spent on unnecessary investigations for somatoform patients are time and resources not available for patients with genuine organic disease |
| Diagnostic overshadowing | Once a patient is "labelled" as having a somatoform disorder, future clinicians may dismiss new symptoms as functional without adequate assessment → genuine organic disease may be missed. This is the flip side of over-investigation — and it is equally dangerous. |
Diagnostic Overshadowing — The Other Danger
After a patient is diagnosed with a somatoform disorder, there is a real risk that all future complaints will be attributed to the psychiatric condition without adequate medical assessment. Patients with somatoform disorders can — and do — develop genuine organic diseases (cancer, autoimmune conditions, infections). Every new symptom deserves a fresh clinical evaluation, even in a patient with known SSD. The adage applies: "just because the patient has cried wolf before does not mean there is never a wolf."
| Condition | Specific Complications |
|---|---|
| Somatic Symptom Disorder | Unnecessary invasive procedures with iatrogenic complications [2]; substance use disorders [2]; chronic disability; financial ruin from medical expenses |
| Illness Anxiety Disorder | Chronic course (persists in 40–70%) not influenced by comorbid anxiety/depression [2]; relationship breakdown due to constant illness preoccupation; radiation exposure from repeated imaging |
| Functional Neurological Symptom Disorder | Symptom reinforcement by treatment measures (e.g., providing wheelchair entrenches paralysis) [2]; secondary physical complications of immobility (DVT, pressure sores, contractures, pneumonia) if motor symptoms are prolonged; misdiagnosis as epilepsy leading to unnecessary anticonvulsant therapy with its own side effects (if PNES misidentified as epileptic seizures) |
| Body Dysmorphic Disorder | Suicide (80% ideation, 25% attempt) [2]; unnecessary cosmetic surgery (which typically worsens the condition — patients are dissatisfied with results and seek further procedures); social isolation and housebound status; skin damage from compulsive skin picking |
Understanding which patients are at higher risk of complications helps guide the intensity of follow-up:
| Factor | Direction | Explanation |
|---|---|---|
| Older age | Worse prognosis [2] | Longer illness duration, more entrenched patterns, less cognitive flexibility for CBT, higher risk of comorbid organic disease |
| Number and severity of complaints | Worse prognosis [2] | Higher symptom burden = more healthcare utilisation = more opportunities for iatrogenic harm |
| Comorbid depression/anxiety | Worse prognosis [2] | Amplifies symptom perception, reduces treatment engagement, introduces suicide risk |
| Maladaptive personality traits | Worse prognosis [2] | Harm avoidance (excessive caution about health), low cooperativeness (difficulty with therapeutic alliance) [2] |
| Younger age at presentation | Better prognosis | More neuroplasticity, fewer entrenched patterns |
| Good insight | Better prognosis | Patients who recognise their worry is disproportionate are more amenable to CBT |
| Strong social support | Better prognosis | Reduces isolation and deconditioning |
High Yield Summary — Complications
Iatrogenic complications (most important and most preventable):
- False positives and incidental findings trigger invasive cascade
- Unnecessary surgeries (exploratory laparotomy, hysterectomy, cholecystectomy) → post-operative pain, adhesions, NO symptom relief
- Cumulative radiation from repeated CTs
- Prevention: judicious investigation, single primary clinician, scheduled appointments
Substance use disorders [2]:
- Narcotic analgesics and benzodiazepines are the main culprits
- Mechanism: rapid relief → tolerance → dose escalation → dependence → withdrawal symptoms mimic original complaints
- Prevention: avoid opioids and long-term BZDs in somatoform patients
Psychiatric comorbidity:
- Depression (30–60%), GAD (71% in IAD), panic (36% in FND), dissociation (47% in FND), personality disorders (77% in IAD)
- Suicide risk especially in BDD (80% ideation, 25% attempt)
Functional impairment:
- Occupational disability, social isolation, relationship breakdown, physical deconditioning
- Deconditioning creates genuine physical symptoms → self-perpetuating cycle
Diagnostic overshadowing:
- Once labelled, new organic disease may be missed
- Every new symptom deserves fresh clinical evaluation
Negative prognostic factors: older age, more complaints, comorbid depression/anxiety, maladaptive personality traits (harm avoidance, low cooperativeness) [2]
Active Recall - Complications of Somatoform Disorders
References
[2] Senior notes: ryanho-psych.md (Sections 8.4.2.1, 8.4.2.2, 8.4.2.3 — clinical course and complications of somatic symptom disorder, illness anxiety disorder, conversion disorder, body dysmorphic disorder, factitious disorder)
High Yield Summary
Definition: Somatoform disorders = psychiatric conditions where physical symptoms cause significant distress with disproportionate maladaptive thoughts, feelings, and behaviours. DSM-5 renamed these "Somatic Symptom and Related Disorders."
Key Conceptual Shift (DSM-5): No longer requires symptoms to be "medically unexplained" — focuses on the disproportionate response to symptoms.
Epidemiology: 4–6% general population, 17% primary care. F > M. Onset in adolescence/early adulthood. Lower SES and education.
Aetiology — Biopsychosocial:
- Biological: Genetics (7–21% heritability), neurobiological alterations in emotion-body schema processing
- Psychological: Amplifying perceptual style, illness-related beliefs, alexithymia, psychodynamic conversion
- Social: Childhood adversity/abuse, low SES, cultural suppression of emotional expression (highly relevant in Hong Kong)
Classification (DSM-5):
- Somatic Symptom Disorder (SSD): ≥1 distressing somatic symptom + disproportionate response (≥6 months)
- Illness Anxiety Disorder (IAD): Preoccupation with serious illness, minimal/no somatic symptoms
- Functional Neurological Symptom Disorder (FND): Neurological symptoms incompatible with recognised disease
- Body Dysmorphic Disorder: Now under OCD-related disorders
Key Clinical Features:
- Multiple somatic symptoms across systems (pain, GI, CVS, neuro, urogenital)
- Disproportionate worry, checking behaviours, doctor-shopping
- Negative workups do NOT reassure
- Comorbid anxiety/depression in 30–60%
Critical Distinctions:
- Somatoform = unconscious/unconscious/psychological distress
- Factitious = unconscious/conscious/sick role
- Malingering = conscious/deliberate/external gain
Course: Chronic, fluctuating. 50–75% improve, rarely fully resolve. Complications: iatrogenic harm from unnecessary procedures, substance use disorders.
Investigation Principle: Be judicious — too many investigations reinforce illness behaviour and risk iatrogenic harm.
High Yield Summary — Differential Diagnosis
Step 1: Always exclude organic disease first — SLE, MS, hyperparathyroidism, thyroid disorders, occult malignancy, HIV, chronic infections, phaeochromocytoma.
Step 2: Distinguish unconscious vs conscious symptom production — somatoform (unconscious/unconscious) vs factitious (unconscious motivation/conscious fabrication) vs malingering (conscious/conscious, external gain).
Step 3: Within the somatoform spectrum — differentiate by (a) whether symptoms are neurological (FND), (b) whether symptoms are minimal with preoccupation about having disease (IAD), (c) whether concern is about appearance (BDD), or (d) whether there is disproportionate response to prominent somatic symptoms (SSD).
Step 4: Distinguish from other psychiatric disorders — Depression (symptoms remit outside episodes), GAD (anxiety pervasive beyond health), Panic disorder (episodic, anticipatory anxiety about attacks), OCD (intrusive, ego-dystonic thoughts with ritualistic compulsions), Delusional disorder (fixed, unshakeable beliefs at delusional intensity), PTSD (trauma exposure required), Adjustment disorder (identifiable stressor, self-limiting).
Key DSM-5 principle: The presence of organic disease does NOT exclude SSD. The absence of organic disease does NOT alone qualify for SSD. The diagnosis is about the disproportionate response.
High Yield Summary — Diagnosis
Somatic Symptom Disorder (DSM-5):
- Criterion A: ≥1 distressing somatic symptom (medically explained or not)
- Criterion B: Disproportionate thoughts (catastrophising), anxiety about health, OR excessive time/energy devoted to symptoms — at least ONE required
- Criterion C: Persistent state of being symptomatic, typically > 6 months
- Key difference from ICD-10: DSM-5 does NOT require symptoms to be medically unexplained; ICD-10 requires ≥2 years + no physical explanation + refusal of reassurance
Illness Anxiety Disorder (DSM-5):
- Preoccupation with having/acquiring serious illness + minimal/no somatic symptoms + ≥6 months
- Two subtypes: care-seeking vs care-avoidant
- If prominent somatic symptoms present → SSD, not IAD
Functional Neurological Symptom Disorder (DSM-5):
- Neurological symptoms with clinical evidence of INCOMPATIBILITY with recognised disease
- Requires POSITIVE signs (Hoover's, entrainment, non-anatomical sensory loss) — NOT just normal investigations
- No longer requires identified psychological stressor
Investigation Principles:
- Judicious and targeted, not exhaustive
- Each test must answer a specific clinical question
- False positives are dangerous — may trigger iatrogenic cascade
- Normal results do NOT reassure somatoform patients
- Review old records before repeating investigations
High Yield Summary — Management
Foundation (ALL somatoform disorders):
- Therapeutic relationship is the treatment
- Emphasise symptoms are real; explain psychosocial factors; offer biopsychosocial explanation
- Scheduled appointments, single clinician, limit investigations
- Treat comorbid depression/anxiety (SSRI + CBT)
Psychotherapy:
- CBT is first-line formal psychotherapy for all somatoform subtypes
- Targets: dysfunctional health beliefs (cognitive restructuring), maladaptive behaviours (ERP/behavioural experiments), psychoeducation (attention-amplification model)
- 70–90% decline psychotherapy — engagement is the biggest barrier
- MBCT is second-line, especially for IAD
Pharmacotherapy:
- SSRIs first-line (start low, go slow — amplifying perceptual style makes patients hypersensitive to side effects)
- SNRIs useful for pain-predominant presentations (duloxetine for fibromyalgia/chronic pain)
- Low-dose TCAs (amitriptyline) for chronic pain and insomnia
- BZDs: SHORT-TERM only (max 1 month), high risk of dependence — avoid in somatoform disorders
- Propranolol for peripheral autonomic symptoms only
FND-specific:
- Psychoeducation (1st line) → Physiotherapy for motor / CBT for other symptoms (2nd line)
- Do NOT reinforce symptoms with wheelchair/mobility aids
Key Pitfalls:
- Never tell patients "it's all in your head"
- Never prescribe long-term benzodiazepines or opioids
- Never order investigations to "reassure" — it doesn't work
- Never provide mobility aids without active rehabilitation plan for FND
High Yield Summary — Complications
Iatrogenic complications (most important and most preventable):
- False positives and incidental findings trigger invasive cascade
- Unnecessary surgeries (exploratory laparotomy, hysterectomy, cholecystectomy) → post-operative pain, adhesions, NO symptom relief
- Cumulative radiation from repeated CTs
- Prevention: judicious investigation, single primary clinician, scheduled appointments
Substance use disorders [2]:
- Narcotic analgesics and benzodiazepines are the main culprits
- Mechanism: rapid relief → tolerance → dose escalation → dependence → withdrawal symptoms mimic original complaints
- Prevention: avoid opioids and long-term BZDs in somatoform patients
Psychiatric comorbidity:
- Depression (30–60%), GAD (71% in IAD), panic (36% in FND), dissociation (47% in FND), personality disorders (77% in IAD)
- Suicide risk especially in BDD (80% ideation, 25% attempt)
Functional impairment:
- Occupational disability, social isolation, relationship breakdown, physical deconditioning
- Deconditioning creates genuine physical symptoms → self-perpetuating cycle
Diagnostic overshadowing:
- Once labelled, new organic disease may be missed
- Every new symptom deserves fresh clinical evaluation
Negative prognostic factors: older age, more complaints, comorbid depression/anxiety, maladaptive personality traits (harm avoidance, low cooperativeness) [2]
Obsessive-compulsive Disorder
Obsessive-compulsive disorder is a chronic psychiatric condition characterized by intrusive, unwanted thoughts (obsessions) and repetitive behaviors or mental acts (compulsions) performed to reduce the resulting anxiety.
Stress-related Disorders
Stress-related disorders are a group of conditions in which identifiable psychosocial stressors or traumatic events lead to clinically significant emotional, behavioral, or physiological symptoms, including acute stress disorder, post-traumatic stress disorder, and adjustment disorders.